{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T05:33:08Z","timestamp":1794893588276,"version":"4.9.1"},"reference-count":287,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3602900"],"award-info":[{"award-number":["2022YFC3602900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372831"],"award-info":[{"award-number":["82372831"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Gut microbiota\u2013derived metabolites are emerging as systemic \u201cremote immunoregulators\u201d that shape tumor immunity across tissues. Integrating evidence across short-chain fatty acids, tryptophan derivatives, secondary bile acids, polyamines and other metabolites, we advance a metabolite\u2013immune pathway\u2013cancer framework that links receptor-mediated signaling, epigenetic remodeling and metabolic reprogramming to context-dependent, bidirectional immune effects. Importantly, in addition to the g protein-coupled receptor \/ aryl hydrocarbon receptor pathway, the selected microbial small molecule metabolites are the true T-cell receptor ligands of unconventional T cells, directly shaping the tissue resident immune and tumor microenvironment, supplementing the receptor signaling and epigenetic programs in our framework. We synthesize how these metabolites recalibrate the tumor immune microenvironment\u2014modulating antigen presentation, T-cell effector fitness and exhaustion, regulatory T-cell activity, and myeloid polarization\u2014and why the same metabolite can either potentiate immune surveillance or entrench immunosuppression depending on ligand\u2013receptor pairing, dose and tissue niche. We compare tumor-type specific patterns (e.g., colorectal, liver, lung, breast and prostate cancers) to highlight common circuits and organ-restricted idiosyncrasies. Methodologically, we outline how single-cell and spatial multi-omics, imaging mass spectrometry and functional biosensors now enable co-registration of metabolite exposure with immune-cell states in human tumors, providing an actionable basis for biomarker discovery. Given ongoing debate about signals attributed to intratumoral microbiota in low-biomass tumor tissues, we foreground quantifiable, spatially mappable and pharmacologically tractable metabolite\u2013receptor pathways, using microbe-associated molecular patterns \/ translocation as comparators to judge when chemical signals should be prioritized as intervention targets. Finally, we evaluate precision intervention avenues\u2014including fecal microbiota transplantation, rational bacterial consortia, engineered microbes and nanoparticle-enabled metabolite delivery\u2014and propose stratification rules that pair metabolite\/receptor signatures with fit-for-purpose delivery. Together, mapping tissue-specific metabolite\u2013immune circuits and embedding them in robust biomarker frameworks may convert microbial metabolites from correlative markers into therapeutic targets and tools, improving the efficacy and durability of cancer immunotherapy.<\/jats:p>","DOI":"10.1186\/s12943-025-02521-5","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T04:27:11Z","timestamp":1764736031000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Gut microbial metabolites in cancer immunomodulation"],"prefix":"10.1186","volume":"25","author":[{"given":"Hengshuo","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weichao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"2521_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"2521_CR2","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1126\/science.1203486","volume":"331","author":"RD Schreiber","year":"2011","unstructured":"Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion. Science. 2011;331:1565\u201370.","journal-title":"Science"},{"key":"2521_CR3","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41586-022-04735-9","volume":"606","author":"M \u0141uksza","year":"2022","unstructured":"\u0141uksza M, Sethna ZM, Rojas LA, Lihm J, Bravi B, Elhanati Y, et al. Neoantigen quality predicts immunoediting in survivors of pancreatic cancer. Nature. 2022;606:389\u201395.","journal-title":"Nature"},{"key":"2521_CR4","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","volume":"56","author":"I Mellman","year":"2023","unstructured":"Mellman I, Chen DS, Powles T, Turley SJ. The cancer-immunity cycle: indication, genotype, and immunotype. Immunity. 2023;56:2188\u2013205.","journal-title":"Immunity"},{"key":"2521_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06976-0","volume":"15","author":"L Co\u00ebnon","year":"2024","unstructured":"Co\u00ebnon L, Geindreau M, Ghiringhelli F, Villalba M, Bruchard M. Natural killer cells at the frontline in the fight against cancer. Cell Death Dis. 2024;15:614.","journal-title":"Cell Death Dis"},{"key":"2521_CR6","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1093\/annonc\/mdw168","volume":"27","author":"JM Pitt","year":"2016","unstructured":"Pitt JM, Marabelle A, Eggermont A, Soria JC, Kroemer G, Zitvogel L. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy. Ann Oncol. 2016;27:1482\u201392.","journal-title":"Ann Oncol"},{"key":"2521_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01282-8","volume":"15","author":"Y Tie","year":"2022","unstructured":"Tie Y, Tang F, Wei YQ, Wei XW. Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets. J Hematol Oncol. 2022;15:61.","journal-title":"J Hematol Oncol"},{"key":"2521_CR8","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1038\/s12276-023-01080-3","volume":"55","author":"J Yang","year":"2023","unstructured":"Yang J, Bae H. Drug conjugates for targeting regulatory T cells in the tumor microenvironment: guided missiles for cancer treatment. Exp Mol Med. 2023;55:1996\u20132004.","journal-title":"Exp Mol Med"},{"key":"2521_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. 2018;359:97\u2013103.","journal-title":"Science"},{"key":"2521_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.723846","volume":"9","author":"X Xiong","year":"2022","unstructured":"Xiong X, Liao X, Qiu S, Xu H, Zhang S, Wang S, et al. CXCL8 in tumor biology and its implications for clinical translation. Front Mol Biosci. 2022;9:723846.","journal-title":"Front Mol Biosci"},{"key":"2521_CR11","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","volume":"359","author":"A Ribas","year":"2018","unstructured":"Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade. Science. 2018;359:1350\u20135.","journal-title":"Science"},{"key":"2521_CR12","doi-asserted-by":"publisher","unstructured":"Sepich-Poore GD, Zitvogel L, Straussman R, Hasty J, Wargo JA, Knight R. The Microbiome and human cancer. Sci. 2021;371(6536):eabc4552. https:\/\/doi.org\/10.1126\/science.abc4552","DOI":"10.1126\/science.abc4552"},{"key":"2521_CR13","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/s41577-021-00534-x","volume":"21","author":"M Schmitt","year":"2021","unstructured":"Schmitt M, Greten FR. The inflammatory pathogenesis of colorectal cancer. Nat Rev Immunol. 2021;21:653\u201367.","journal-title":"Nat Rev Immunol"},{"key":"2521_CR14","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.cmet.2021.03.002","volume":"33","author":"Y He","year":"2021","unstructured":"He Y, Fu L, Li Y, Wang W, Gong M, Zhang J, et al. Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8(+) T cell immunity. Cell Metab. 2021;33:988\u2013e10001007.","journal-title":"Cell Metab"},{"key":"2521_CR15","doi-asserted-by":"publisher","unstructured":"Shi Y, Zheng W, Yang K, Harris KG, Ni K, Xue L, et al. Lin W, Chang EB, Weichselbaum RR, Fu YX. Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling. J Exp Med 2020, 217(5):e20192282. https:\/\/doi.org\/10.1084\/jem.20192282","DOI":"10.1084\/jem.20192282"},{"key":"2521_CR16","doi-asserted-by":"publisher","first-page":"eabo2296","DOI":"10.1126\/science.abo2296","volume":"380","author":"M Fidelle","year":"2023","unstructured":"Fidelle M, Rauber C, Alves Costa Silva C, Tian AL, Lahmar I, de La Varende AM, Zhao L, Thelemaque C, Lebhar I, Messaoudene M, et al. A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers. Science. 2023;380:eabo2296.","journal-title":"Science"},{"key":"2521_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-01845-6","volume":"40","author":"Y Ge","year":"2021","unstructured":"Ge Y, Wang X, Guo Y, Yan J, Abuduwaili A, Aximujiang K, et al. Gut microbiota influence tumor development and alter interactions with the human immune system. J Exp Clin Cancer Res. 2021;40:42.","journal-title":"J Exp Clin Cancer Res"},{"key":"2521_CR18","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/s43018-023-00602-2","volume":"4","author":"J Queen","year":"2023","unstructured":"Queen J, Shaikh F, Sears CL. Understanding the mechanisms and translational implications of the microbiome for cancer therapy innovation. Nat Cancer. 2023;4:1083\u201394.","journal-title":"Nat Cancer"},{"key":"2521_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.tem.2024.06.016","volume":"36","author":"P Song","year":"2025","unstructured":"Song P, Peng Z, Guo X. Gut microbial metabolites in cancer therapy. Trends Endocrinol Metab. 2025;36:55\u201369.","journal-title":"Trends Endocrinol Metab"},{"key":"2521_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2023.12.009","volume":"57","author":"M Arifuzzaman","year":"2024","unstructured":"Arifuzzaman M, Collins N, Guo CJ, Artis D. Nutritional regulation of microbiota-derived metabolites: implications for immunity and inflammation. Immunity. 2024;57:14\u201327.","journal-title":"Immunity"},{"key":"2521_CR21","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1126\/science.aaz7015","volume":"374","author":"CN Spencer","year":"2021","unstructured":"Spencer CN, McQuade JL, Gopalakrishnan V, McCulloch JA, Vetizou M, Cogdill AP, et al. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response. Science. 2021;374:1632\u201340.","journal-title":"Science"},{"issue":"2","key":"2521_CR22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.chom.2016.07.001","volume":"20","author":"M Kim","year":"2016","unstructured":"Kim M, Qie Y, Park J, Kim CH. Gut microbial metabolites fuel host antibody responses. Cell Host Microbe. 2016;20(2):202\u201314.","journal-title":"Cell Host Microbe"},{"issue":"1","key":"2521_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22212-1","volume":"12","author":"A Nakamura","year":"2021","unstructured":"Nakamura A, Kurihara S, Takahashi D, Ohashi W, Nakamura Y, Kimura S, et al. Symbiotic polyamine metabolism regulates epithelial proliferation and macrophage differentiation in the colon. Nat Commun. 2021;12(1):2105.","journal-title":"Nat Commun"},{"key":"2521_CR24","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1126\/science.abc3421","volume":"369","author":"LF Mager","year":"2020","unstructured":"Mager LF, Burkhard R, Pett N, Cooke NCA, Brown K, Ramay H, et al. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science. 2020;369:1481\u20139.","journal-title":"Science"},{"key":"2521_CR25","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","volume":"165","author":"A Koh","year":"2016","unstructured":"Koh A, De Vadder F, Kovatcheva-Datchary P, B\u00e4ckhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016;165:1332\u201345.","journal-title":"Cell"},{"key":"2521_CR26","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2409209","volume":"16","author":"D Jia","year":"2024","unstructured":"Jia D, Kuang Z, Wang L. The role of microbial indole metabolites in tumor. Gut Microbes. 2024;16:2409209.","journal-title":"Gut Microbes"},{"key":"2521_CR27","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nature11605","volume":"491","author":"L Kjer-Nielsen","year":"2012","unstructured":"Kjer-Nielsen L, Patel O, Corbett AJ, Le Nours J, Meehan B, Liu L, et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature. 2012;491:717\u201323.","journal-title":"Nature"},{"key":"2521_CR28","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/ni.2096","volume":"12","author":"Y Kinjo","year":"2011","unstructured":"Kinjo Y, Illarionov P, Vela JL, Pei B, Girardi E, Li X, et al. Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria. Nat Immunol. 2011;12:966\u201374.","journal-title":"Nat Immunol"},{"key":"2521_CR29","doi-asserted-by":"publisher","unstructured":"Rigau M, Ostrouska S, Fulford TS, Johnson DN, Woods K, Ruan Z, et al. Butyrophilin 2A1 is essential for phosphoantigen reactivity by \u03b3\u03b4 T cells. Sci. 2020;367(6478):eaay5516. https:\/\/doi.org\/10.1126\/science.aay5516","DOI":"10.1126\/science.aay5516"},{"key":"2521_CR30","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41586-023-06525-3","volume":"621","author":"L Yuan","year":"2023","unstructured":"Yuan L, Ma X, Yang Y, Qu Y, Li X, Zhu X, et al. Phosphoantigens glue butyrophilin 3A1 and 2A1 to activate V\u03b39V\u03b42 T cells. Nature. 2023;621:840\u20138.","journal-title":"Nature"},{"key":"2521_CR31","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature12721","volume":"504","author":"Y Furusawa","year":"2013","unstructured":"Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013;504:446\u201350.","journal-title":"Nature"},{"key":"2521_CR32","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.cell.2023.03.011","volume":"186","author":"MJ Bender","year":"2023","unstructured":"Bender MJ, McPherson AC, Phelps CM, Pandey SP, Laughlin CR, Shapira JH, Medina Sanchez L, Rana M, Richie TG, Mims TS, et al. Dietary Tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment. Cell. 2023;186:1846\u2013e18621826.","journal-title":"Cell"},{"key":"2521_CR33","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.immuni.2024.02.014","volume":"57","author":"J Cong","year":"2024","unstructured":"Cong J, Liu P, Han Z, Ying W, Li C, Yang Y, Wang S, Yang J, Cao F, Shen J, et al. Bile acids modified by the intestinal microbiota promote colorectal cancer growth by suppressing CD8(+) T cell effector functions. Immunity. 2024;57:876\u2013e889811.","journal-title":"Immunity"},{"issue":"75","key":"2521_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abn0704","volume":"7","author":"G Mirji","year":"2022","unstructured":"Mirji G, Worth A, Bhat SA, El Sayed M, Kannan T, Goldman AR, et al. The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer. Sci Immunol. 2022;7(75):eabn0704.","journal-title":"Sci Immunol"},{"key":"2521_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41938-8","volume":"14","author":"MM Karunakaran","year":"2023","unstructured":"Karunakaran MM, Subramanian H, Jin Y, Mohammed F, Kimmel B, Juraske C, et al. A distinct topology of BTN3A IgV and B30.2 domains controlled by juxtamembrane regions favors optimal human \u03b3\u03b4 T cell phosphoantigen sensing. Nat Commun. 2023;14:7617.","journal-title":"Nat Commun"},{"key":"2521_CR36","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/s41590-023-01575-1","volume":"24","author":"LC Garner","year":"2023","unstructured":"Garner LC, Amini A, FitzPatrick MEB, Lett MJ, Hess GF, Filipowicz Sinnreich M, et al. Single-cell analysis of human MAIT cell transcriptional, functional and clonal diversity. Nat Immunol. 2023;24:1565\u201378.","journal-title":"Nat Immunol"},{"key":"2521_CR37","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1126\/science.1240537","volume":"342","author":"S Viaud","year":"2013","unstructured":"Viaud S, Saccheri F, Mignot G, Yamazaki T, Daill\u00e8re R, Hannani D, et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science. 2013;342:971\u20136.","journal-title":"Science"},{"key":"2521_CR38","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aah5043","volume":"357","author":"LT Geller","year":"2017","unstructured":"Geller LT, Barzily-Rokni M, Danino T, Jonas OH, Shental N, Nejman D, et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017;357:1156\u201360.","journal-title":"Science"},{"key":"2521_CR39","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.aay9189","volume":"368","author":"D Nejman","year":"2020","unstructured":"Nejman D, Livyatan I, Fuks G, Gavert N, Zwang Y, Geller LT, et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science. 2020;368:973\u201380.","journal-title":"Science"},{"key":"2521_CR40","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ads6335","volume":"17","author":"Y Ge","year":"2025","unstructured":"Ge Y, Lu J, Puiu D, Revsine M, Salzberg SL. Comprehensive analysis of microbial content in whole-genome sequencing samples from the cancer genome atlas project. Sci Transl Med. 2025;17:eads6335.","journal-title":"Sci Transl Med"},{"key":"2521_CR41","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/s41564-025-02035-2","volume":"10","author":"N Fierer","year":"2025","unstructured":"Fierer N, Leung PM, Lappan R, Eisenhofer R, Ricci F, Holland SI, et al. Guidelines for preventing and reporting contamination in low-biomass microbiome studies. Nat Microbiol. 2025;10:1570\u201380.","journal-title":"Nat Microbiol"},{"key":"2521_CR42","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s42255-025-01287-w","volume":"7","author":"A Nobels","year":"2025","unstructured":"Nobels A, van Marcke C, Jordan BF, Van Hul M, Cani PD. The gut microbiome and cancer: from tumorigenesis to therapy. Nat Metab. 2025;7:895\u2013917.","journal-title":"Nat Metab"},{"key":"2521_CR43","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.trecan.2024.11.003","volume":"11","author":"S Li","year":"2025","unstructured":"Li S, Duan Y, Luo S, Zhou F, Wu Q, Lu Z. Short-chain fatty acids and cancer. Trends Cancer. 2025;11:154\u201368.","journal-title":"Trends Cancer"},{"key":"2521_CR44","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/j.2040-4603.2018.tb00009.x","volume":"8","author":"S Sivaprakasam","year":"2017","unstructured":"Sivaprakasam S, Bhutia YD, Yang S, Ganapathy V. Short-chain fatty acid transporters: role in colonic homeostasis. Compr Physiol. 2017;8:299\u2013314.","journal-title":"Compr Physiol"},{"key":"2521_CR45","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1136\/gutjnl-2023-329543","volume":"72","author":"W Fong","year":"2023","unstructured":"Fong W, Li Q, Ji F, Liang W, Lau HCH, Kang X, et al. Lactobacillus gallinarum-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1\/Kyn\/AHR axis. Gut. 2023;72:2272\u201385.","journal-title":"Gut"},{"key":"2521_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53242-x","volume":"9","author":"H Shimizu","year":"2019","unstructured":"Shimizu H, Masujima Y, Ushiroda C, Mizushima R, Taira S, Ohue-Kitano R, et al. Dietary short-chain fatty acid intake improves the hepatic metabolic condition via FFAR3. Sci Rep. 2019;9:16574.","journal-title":"Sci Rep"},{"key":"2521_CR47","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jcmgh.2020.02.005","volume":"10","author":"V Voronova","year":"2020","unstructured":"Voronova V, Sokolov V, Al-Khaifi A, Straniero S, Kumar C, Peskov K, et al. A physiology-based model of bile acid distribution and metabolism under healthy and pathologic conditions in human beings. Cell Mol Gastroenterol Hepatol. 2020;10:149\u201370.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2521_CR48","doi-asserted-by":"publisher","unstructured":"Ma C, Han M, Heinrich B, Fu Q, Zhang Q, Sandhu M, et al. Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Sci. 2018;360(6391):eaan5931. https:\/\/doi.org\/10.1126\/science.aan5931","DOI":"10.1126\/science.aan5931"},{"key":"2521_CR49","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1158\/2159-8290.CD-20-0304","volume":"11","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Ma C, Duan Y, Heinrich B, Rosato U, Diggs LP, et al. Gut microbiome directs hepatocytes to recruit MDSCs and promote cholangiocarcinoma. Cancer Discov. 2021;11:1248\u201367.","journal-title":"Cancer Discov"},{"key":"2521_CR50","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/j.apsb.2020.12.022","volume":"11","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Lu Y, Qi J, Wu W. An update on oral drug delivery via intestinal lymphatic transport. Acta Pharm Sin B. 2021;11:2449\u201368.","journal-title":"Acta Pharm Sin B"},{"key":"2521_CR51","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1038\/nm.4222","volume":"22","author":"T Eisenberg","year":"2016","unstructured":"Eisenberg T, Abdellatif M, Schroeder S, Primessnig U, Stekovic S, Pendl T, et al. Cardioprotection and lifespan extension by the natural polyamine spermidine. Nat Med. 2016;22:1428\u201338.","journal-title":"Nat Med"},{"key":"2521_CR52","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.chembiol.2024.04.007","volume":"31","author":"X Xu","year":"2024","unstructured":"Xu X, Chen Z, Bartman CR, Xing X, Olszewski K, Rabinowitz JD. One-carbon unit supplementation fuels purine synthesis in tumor-infiltrating T cells and augments checkpoint Blockade. Cell Chem Biol. 2024;31:932\u2013e943938.","journal-title":"Cell Chem Biol"},{"key":"2521_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01529-6","volume":"17","author":"Z Zhao","year":"2024","unstructured":"Zhao Z, Qin J, Qian Y, Huang C, Liu X, Wang N, et al. Ffar2 expressing myeloid-derived suppressor cells drive cancer immunoevasion. J Hematol Oncol. 2024;17:9.","journal-title":"J Hematol Oncol"},{"key":"2521_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-025-00786-8","volume":"11","author":"W Lei","year":"2025","unstructured":"Lei W, Zhou K, Lei Y, Li Q, Zhu H. Gut microbiota shapes cancer immunotherapy responses. NPJ Biofilms Microbiomes. 2025;11:143.","journal-title":"NPJ Biofilms Microbiomes"},{"key":"2521_CR55","doi-asserted-by":"publisher","first-page":"3686","DOI":"10.1016\/j.cell.2023.07.026","volume":"186","author":"B Ruf","year":"2023","unstructured":"Ruf B, Bruhns M, Babaei S, Kedei N, Ma L, Revsine M, Benmebarek MR, Ma C, Heinrich B, Subramanyam V, et al. Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin. Cell. 2023;186:3686\u2013e37053632.","journal-title":"Cell"},{"issue":"74","key":"2521_CR56","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abn6563","volume":"7","author":"G Delfanti","year":"2022","unstructured":"Delfanti G, Cortesi F, Perini A, Antonini G, Azzimonti L, de Lalla C, et al. TCR-engineered iNKT cells induce robust antitumor response by dual targeting cancer and suppressive myeloid cells. Sci Immunol. 2022;7(74):eabn6563.","journal-title":"Sci Immunol"},{"key":"2521_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21928-4","volume":"12","author":"S De Biasi","year":"2021","unstructured":"De Biasi S, Gibellini L, Lo Tartaro D, Puccio S, Rabacchi C, Mazza EMC, et al. Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy. Nat Commun. 2021;12:1669.","journal-title":"Nat Commun"},{"key":"2521_CR58","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nature13160","volume":"509","author":"AJ Corbett","year":"2014","unstructured":"Corbett AJ, Eckle SB, Birkinshaw RW, Liu L, Patel O, Mahony J, et al. T-cell activation by transitory neo-antigens derived from distinct microbial pathways. Nature. 2014;509:361\u20135.","journal-title":"Nature"},{"key":"2521_CR59","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41385-020-0273-y","volume":"13","author":"B Lu","year":"2020","unstructured":"Lu B, Liu M, Wang J, Fan H, Yang D, Zhang L, et al. IL-17 production by tissue-resident MAIT cells is locally induced in children with pneumonia. Mucosal Immunol. 2020;13:824\u201335.","journal-title":"Mucosal Immunol"},{"key":"2521_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25009-4","volume":"12","author":"EV Petley","year":"2021","unstructured":"Petley EV, Koay HF, Henderson MA, Sek K, Todd KL, Keam SP, et al. MAIT cells regulate NK cell-mediated tumor immunity. Nat Commun. 2021;12:4746.","journal-title":"Nat Commun"},{"key":"2521_CR61","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1038\/s12276-023-01053-6","volume":"55","author":"S Kim","year":"2023","unstructured":"Kim S, Cho S, Kim JH. CD1-mediated immune responses in mucosal tissues: molecular mechanisms underlying lipid antigen presentation system. Exp Mol Med. 2023;55:1858\u201371.","journal-title":"Exp Mol Med"},{"key":"2521_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202000609","volume":"7","author":"J Ma","year":"2020","unstructured":"Ma J, He P, Zhao C, Ren Q, Dong Z, Qiu J, et al. A designed \u03b1-GalCer analog promotes considerable Th1 cytokine response by activating the CD1d-iNKT axis and CD11b-positive monocytes\/macrophages. Adv Sci. 2020;7:2000609.","journal-title":"Adv Sci"},{"key":"2521_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39738-1","volume":"14","author":"M Tsuji","year":"2023","unstructured":"Tsuji M, Nair MS, Masuda K, Castagna C, Chong Z, Darling TL, et al. An immunostimulatory glycolipid that blocks SARS-CoV-2, RSV, and influenza infections in vivo. Nat Commun. 2023;14:3959.","journal-title":"Nat Commun"},{"key":"2521_CR64","doi-asserted-by":"publisher","unstructured":"Allamand A, Piechowiak T, Li\u00e8vremont D, Rohmer M, Grosdemange-Billiard C. The multifaceted MEP pathway: towards new therapeutic perspectives. Mol. 2023;28(3):1403. https:\/\/doi.org\/10.3390\/molecules28031403","DOI":"10.3390\/molecules28031403"},{"key":"2521_CR65","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.immuni.2019.02.016","volume":"50","author":"Y Yang","year":"2019","unstructured":"Yang Y, Li L, Yuan L, Zhou X, Duan J, Xiao H, Cai N, Han S, Ma X, Liu W, et al. A structural change in Butyrophilin upon phosphoantigen binding underlies phosphoantigen-Mediated V\u03b39V\u03b42 T cell activation. Immunity. 2019;50:1043\u2013e10531045.","journal-title":"Immunity"},{"key":"2521_CR66","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1158\/2326-6066.CIR-23-0868","volume":"12","author":"AC Le Floch","year":"2024","unstructured":"Le Floch AC, Imbert C, Boucherit N, Gorvel L, Fattori S, Orlanducci F, et al. Targeting BTN2A1 enhances V\u03b39V\u03b42 T-cell effector functions and triggers tumor cell pyroptosis. Cancer Immunol Res. 2024;12:1677\u201390.","journal-title":"Cancer Immunol Res"},{"key":"2521_CR67","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41423-023-00987-1","volume":"20","author":"CH Kim","year":"2023","unstructured":"Kim CH. Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity. Cell Mol Immunol. 2023;20:341\u201350.","journal-title":"Cell Mol Immunol"},{"key":"2521_CR68","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41577-024-01014-8","volume":"24","author":"ER Mann","year":"2024","unstructured":"Mann ER, Lam YK, Uhlig HH. Short-chain fatty acids: linking diet, the microbiome and immunity. Nat Rev Immunol. 2024;24:577\u201395.","journal-title":"Nat Rev Immunol"},{"key":"2521_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24331-1","volume":"12","author":"M Luu","year":"2021","unstructured":"Luu M, Riester Z, Baldrich A, Reichardt N, Yuille S, Busetti A, et al. Microbial short-chain fatty acids modulate CD8(+) T cell responses and improve adoptive immunotherapy for cancer. Nat Commun. 2021;12:4077.","journal-title":"Nat Commun"},{"key":"2521_CR70","doi-asserted-by":"publisher","first-page":"5680","DOI":"10.1016\/j.cell.2025.06.018","volume":"188","author":"CM Phelps","year":"2025","unstructured":"Phelps CM, Willis NB, Duan T, Lee AH, Zhang Y, Rodriguez JD, Pandey SP, Laughlin CR, Rosen ABI, McPherson AC, et al. Exercise-induced microbiota metabolite enhances CD8 T cell antitumor immunity promoting immunotherapy efficacy. Cell. 2025;188:5680\u2013e57005628.","journal-title":"Cell"},{"key":"2521_CR71","doi-asserted-by":"crossref","unstructured":"Xu X, Chen Z, Bartman CR, Xing X, Olszewski K, Rabinowitz JD. One-carbon unit supplementation fuels tumor-infiltrating T cells and augments checkpoint blockade. bioRxiv. 2023.","DOI":"10.1101\/2023.11.01.565193"},{"key":"2521_CR72","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1158\/2159-8290.CD-22-1301","volume":"13","author":"JH Rowe","year":"2023","unstructured":"Rowe JH, Elia I, Shahid O, Gaudiano EF, Sifnugel NE, Johnson S, et al. Formate supplementation enhances antitumor CD8\u2009+\u2009T-cell fitness and efficacy of PD-1 blockade. Cancer Discov. 2023;13:2566\u201383.","journal-title":"Cancer Discov"},{"key":"2521_CR73","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s42255-023-00771-5","volume":"5","author":"AC Green","year":"2023","unstructured":"Green AC, Marttila P, Kiweler N, Chalkiadaki C, Wiita E, Cookson V, et al. Formate overflow drives toxic folate trapping in MTHFD1 inhibited cancer cells. Nat Metab. 2023;5:642\u201359.","journal-title":"Nat Metab"},{"key":"2521_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113034","volume":"42","author":"C Delbrouck","year":"2023","unstructured":"Delbrouck C, Kiweler N, Chen O, Pozdeev VI, Haase L, Neises L, et al. Formate promotes invasion and metastasis in reliance on lipid metabolism. Cell Rep. 2023;42:113034.","journal-title":"Cell Rep"},{"issue":"4","key":"2521_CR75","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s42255-022-00558-0","volume":"4","author":"D Ternes","year":"2022","unstructured":"Ternes D, Tsenkova M, Pozdeev VI, Meyers M, Koncina E, Atatri S, et al. The gut microbial metabolite formate exacerbates colorectal cancer progression. Nat Metab. 2022;4(4):458\u201375.","journal-title":"Nat Metab"},{"key":"2521_CR76","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.immuni.2016.03.016","volume":"44","author":"ML Balmer","year":"2016","unstructured":"Balmer ML, Ma EH, Bantug GR, Gr\u00e4hlert J, Pfister S, Glatter T, et al. Memory CD8(+) T cells require increased concentrations of acetate induced by stress for optimal function. Immunity. 2016;44:1312\u201324.","journal-title":"Immunity"},{"key":"2521_CR77","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1126\/science.aaf6284","volume":"354","author":"M Peng","year":"2016","unstructured":"Peng M, Yin N, Chhangawala S, Xu K, Leslie CS, Li MO. Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism. Science. 2016;354:481\u20134.","journal-title":"Science"},{"key":"2521_CR78","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1016\/j.celrep.2019.04.022","volume":"27","author":"J Qiu","year":"2019","unstructured":"Qiu J, Villa M, Sanin DE, Buck MD, O\u2019Sullivan D, Ching R, Matsushita M, Grzes KM, Winkler F, Chang CH, et al. Acetate promotes T cell effector function during glucose restriction. Cell Rep. 2019;27:2063\u201374. e2065.","journal-title":"Cell Rep"},{"key":"2521_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41817-2","volume":"14","author":"L Ye","year":"2023","unstructured":"Ye L, Hou Y, Hu W, Wang H, Yang R, Zhang Q, et al. Repressed Blautia-acetate immunological axis underlies breast cancer progression promoted by chronic stress. Nat Commun. 2023;14:6160.","journal-title":"Nat Commun"},{"key":"2521_CR80","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1038\/s43018-023-00636-6","volume":"4","author":"KD Miller","year":"2023","unstructured":"Miller KD, O\u2019Connor S, Pniewski KA, Kannan T, Acosta R, Mirji G, et al. Acetate acts as a metabolic immunomodulator by bolstering T-cell effector function and potentiating antitumor immunity in breast cancer. Nat Cancer. 2023;4:1491\u2013507.","journal-title":"Nat Cancer"},{"key":"2521_CR81","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2297846","volume":"16","author":"H Ma","year":"2024","unstructured":"Ma H, Yang L, Liang Y, Liu F, Hu J, Zhang R, et al. B. thetaiotaomicron-derived acetic acid modulate immune microenvironment and tumor growth in hepatocellular carcinoma. Gut Microbes. 2024;16:2297846.","journal-title":"Gut Microbes"},{"key":"2521_CR82","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/s42255-024-01037-4","volume":"6","author":"J Wang","year":"2024","unstructured":"Wang J, Yang Y, Shao F, Meng Y, Guo D, He J, et al. Acetate reprogrammes tumour metabolism and promotes PD-L1 expression and immune evasion by upregulating c-Myc. Nat Metab. 2024;6:914\u201332.","journal-title":"Nat Metab"},{"issue":"5","key":"2521_CR83","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1158\/0008-5472.CAN-20-1847","volume":"81","author":"KD Miller","year":"2021","unstructured":"Miller KD, Pniewski K, Perry CE, Papp SB, Shaffer JD, Velasco-Silva JN, et al. Targeting ACSS2 with a transition-state mimetic inhibits Triple-Negative breast cancer growth. Cancer Res. 2021;81(5):1252\u201364.","journal-title":"Cancer Res"},{"key":"2521_CR84","doi-asserted-by":"publisher","first-page":"15531","DOI":"10.1096\/fj.202000162R","volume":"34","author":"RI H\u00f8gh","year":"2020","unstructured":"H\u00f8gh RI, M\u00f8ller SH, Jepsen SD, Mellergaard M, Lund A, Pejtersen M, et al. Metabolism of short-chain fatty acid propionate induces surface expression of NKG2D ligands on cancer cells. FASEB J. 2020;34:15531\u201346.","journal-title":"FASEB J"},{"key":"2521_CR85","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/s41401-020-00522-2","volume":"42","author":"HS Park","year":"2021","unstructured":"Park HS, Han JH, Park JW, Lee DH, Jang KW, Lee M, et al. Sodium propionate exerts anticancer effect in mice bearing breast cancer cell xenograft by regulating JAK2\/STAT3\/ROS\/p38 MAPK signaling. Acta Pharmacol Sin. 2021;42:1311\u201323.","journal-title":"Acta Pharmacol Sin"},{"key":"2521_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15099-w","volume":"7","author":"C Nastasi","year":"2017","unstructured":"Nastasi C, Fredholm S, Willerslev-Olsen A, Hansen M, Bonefeld CM, Geisler C, et al. Butyrate and propionate inhibit antigen-specific CD8(+) T cell activation by suppressing IL-12 production by antigen-presenting cells. Sci Rep. 2017;7:14516.","journal-title":"Sci Rep"},{"key":"2521_CR87","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature12726","volume":"504","author":"N Arpaia","year":"2013","unstructured":"Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013;504:451\u20135.","journal-title":"Nature"},{"key":"2521_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109332","volume":"36","author":"L Dupraz","year":"2021","unstructured":"Dupraz L, Magniez A, Rolhion N, Richard ML, Da Costa G, Touch S, et al. Gut microbiota-derived short-chain fatty acids regulate IL-17 production by mouse and human intestinal \u03b3\u03b4 T cells. Cell Rep. 2021;36:109332.","journal-title":"Cell Rep"},{"key":"2521_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16079-x","volume":"11","author":"C Coutzac","year":"2020","unstructured":"Coutzac C, Jouniaux JM, Paci A, Schmidt J, Mallardo D, Seck A, et al. Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer. Nat Commun. 2020;11:2168.","journal-title":"Nat Commun"},{"issue":"11","key":"2521_CR90","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1136\/gutjnl-2023-330291","volume":"72","author":"X Kang","year":"2023","unstructured":"Kang X, Liu C, Ding Y, Ni Y, Ji F, Lau HCH, et al. Roseburia intestinalis generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8(+) T cells. Gut. 2023;72(11):2112\u201322.","journal-title":"Gut"},{"key":"2521_CR91","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.ccell.2024.08.019","volume":"42","author":"X Wang","year":"2024","unstructured":"Wang X, Fang Y, Liang W, Wong CC, Qin H, Gao Y, Liang M, Song L, Zhang Y, Fan M, et al. Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer. Cancer Cell. 2024;42:1729\u2013e17461728.","journal-title":"Cancer Cell"},{"key":"2521_CR92","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2249143","volume":"15","author":"X Zhu","year":"2023","unstructured":"Zhu X, Li K, Liu G, Wu R, Zhang Y, Wang S, et al. Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell. Gut Microbes. 2023;15:2249143.","journal-title":"Gut Microbes"},{"key":"2521_CR93","doi-asserted-by":"publisher","unstructured":"Gazzaniga FS, Kasper DL. The gut Microbiome and cancer response to immune checkpoint inhibitors. J Clin Invest. 2025;135(3):e184321. https:\/\/doi.org\/10.1172\/JCI184321","DOI":"10.1172\/JCI184321"},{"key":"2521_CR94","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1172\/JCI124332","volume":"130","author":"M Uribe-Herranz","year":"2020","unstructured":"Uribe-Herranz M, Rafail S, Beghi S, Gil-de-G\u00f3mez L, Verginadis I, Bittinger K, et al. Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response. J Clin Invest. 2020;130:466\u201379.","journal-title":"J Clin Invest"},{"key":"2521_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1328263","volume":"15","author":"CD Thome","year":"2024","unstructured":"Thome CD, Tausche P, Hohenberger K, Yang Z, Krammer S, Trufa DI, et al. Short-chain fatty acids induced lung tumor cell death and increased peripheral blood CD4\u2009+\u2009T cells in NSCLC and control patients ex vivo. Front Immunol. 2024;15:1328263.","journal-title":"Front Immunol"},{"key":"2521_CR96","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.cmet.2020.03.003","volume":"31","author":"EC Rosser","year":"2020","unstructured":"Rosser EC, Piper CJM, Matei DE, Blair PA, Rendeiro AF, Orford M, Alber DG, Krausgruber T, Catalan D, Klein N, et al. Microbiota-Derived metabolites suppress arthritis by amplifying Aryl-Hydrocarbon receptor activation in regulatory B cells. Cell Metab. 2020;31:837\u2013e851810.","journal-title":"Cell Metab"},{"key":"2521_CR97","doi-asserted-by":"publisher","unstructured":"Kim N, Yang C. Sodium butyrate inhibits the expression of thymidylate synthase and induces cell death in colorectal cancer cells. Int J Mol Sci. 2024;25(3):1572. https:\/\/doi.org\/10.3390\/ijms25031572","DOI":"10.3390\/ijms25031572"},{"key":"2521_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18262-6","volume":"11","author":"W Yang","year":"2020","unstructured":"Yang W, Yu T, Huang X, Bilotta AJ, Xu L, Lu Y, et al. Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity. Nat Commun. 2020;11:4457.","journal-title":"Nat Commun"},{"key":"2521_CR99","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2307542","volume":"16","author":"X Yu","year":"2024","unstructured":"Yu X, Ou J, Wang L, Li Z, Ren Y, Xie L, et al. Gut microbiota modulate CD8(+) T cell immunity in gastric cancer through butyrate\/GPR109A\/HOPX. Gut Microbes. 2024;16:2307542.","journal-title":"Gut Microbes"},{"key":"2521_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102822","volume":"65","author":"Y He","year":"2023","unstructured":"He Y, Ling Y, Zhang Z, Mertens RT, Cao Q, Xu X, et al. Butyrate reverses ferroptosis resistance in colorectal cancer by inducing c-Fos-dependent xCT suppression. Redox Biol. 2023;65:102822.","journal-title":"Redox Biol"},{"key":"2521_CR101","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1007\/s13402-023-00831-8","volume":"46","author":"X Yang","year":"2023","unstructured":"Yang X, Zhang Z, Shen X, Xu J, Weng Y, Wang W, et al. Clostridium butyricum and its metabolite butyrate promote ferroptosis susceptibility in pancreatic ductal adenocarcinoma. Cell Oncol (Dordr). 2023;46:1645\u201358.","journal-title":"Cell Oncol (Dordr)"},{"key":"2521_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.116927","volume":"237","author":"Q Chang","year":"2025","unstructured":"Chang Q, Mao H, Feng J, Rao L, Tang W, Zhang Z, et al. Sodium butyrate increases USP5-mediated ubiquitination degradation of GPX4 and enhances anti-cancer efficacy of anti-PD-1 antibody. Biochem Pharmacol. 2025;237:116927.","journal-title":"Biochem Pharmacol"},{"key":"2521_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-29731-5","volume":"13","author":"V Zaiatz-Bittencourt","year":"2023","unstructured":"Zaiatz-Bittencourt V, Jones F, Tosetto M, Scaife C, Cagney G, Jones E, et al. Butyrate limits human natural killer cell effector function. Sci Rep. 2023;13:2715.","journal-title":"Sci Rep"},{"key":"2521_CR104","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202405003","volume":"14","author":"VD Wegner","year":"2025","unstructured":"Wegner VD, Feile A, Alb M, Hudecek M, Hewitt P, Mosig AS. Short-chain fatty acids modulate anti-ROR1 CAR T-cell function and exhaustion in an intestinal adenocarcinoma-on-chip model. Adv Healthc Mater. 2025;14:e2405003.","journal-title":"Adv Healthc Mater"},{"key":"2521_CR105","doi-asserted-by":"crossref","unstructured":"Staudt S, Nikolka F, Perl M, Franz J, Leblay N, Yuan XK, Larrayoz M, Lozano T, Warmuth L, Fante MA et al. Metabolization of microbial postbiotic pentanoate drives anti-cancer CAR T cells. bioRxiv 2025.","DOI":"10.1101\/2024.08.19.608538"},{"key":"2521_CR106","doi-asserted-by":"publisher","unstructured":"Hou Y, Li J, Ying S. Tryptophan metabolism and gut microbiota: A novel regulatory axis integrating the Microbiome, Immunity, and cancer. Metabolites. 2023;13(11):1166. https:\/\/doi.org\/10.3390\/metabo13111166","DOI":"10.3390\/metabo13111166"},{"key":"2521_CR107","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/j.cell.2024.02.022","volume":"187","author":"D Jia","year":"2024","unstructured":"Jia D, Wang Q, Qi Y, Jiang Y, He J, Lin Y, Sun Y, Xu J, Chen W, Fan L, et al. Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer. Cell. 2024;187:1651\u2013e16651621.","journal-title":"Cell"},{"key":"2521_CR108","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.2174\/0929867330666230607104441","volume":"31","author":"A Romo-Perez","year":"2024","unstructured":"Romo-Perez A, Dom\u00ednguez-G\u00f3mez G, Ch\u00e1vez-Blanco AD, Gonz\u00e1lez-Fierro A, Correa-Basurto J, Due\u00f1as-Gonz\u00e1lez A. PaSTe. Blockade of the lipid phenotype of prostate cancer as metabolic therapy: a theoretical proposal. Curr Med Chem. 2024;31:3265\u201385.","journal-title":"Curr Med Chem"},{"key":"2521_CR109","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.immuni.2022.01.006","volume":"55","author":"K Hezaveh","year":"2022","unstructured":"Hezaveh K, Shinde RS, Kl\u00f6tgen A, Halaby MJ, Lamorte S, Ciudad MT, Quevedo R, Neufeld L, Liu ZQ, Jin R, et al. Tryptophan-derived microbial metabolites activate the Aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity. Immunity. 2022;55:324\u2013e340328.","journal-title":"Immunity"},{"key":"2521_CR110","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1136\/gutjnl-2020-323951","volume":"71","author":"N Sugimura","year":"2021","unstructured":"Sugimura N, Li Q, Chu ESH, Lau HCH, Fong W, Liu W, et al. Lactobacillus gallinarum modulates the gut microbiota and produces anti-cancer metabolites to protect against colorectal tumourigenesis. Gut. 2021;71:2011\u201321.","journal-title":"Gut"},{"key":"2521_CR111","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.cmet.2023.04.015","volume":"35","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Zhao Q, Li T, Lu L, Wang F, Zhang H, Liu Z, Ma H, Zhu Q, Wang J, et al. Lactobacillus plantarum-derived indole-3-lactic acid ameliorates colorectal tumorigenesis via epigenetic regulation of CD8(+) T cell immunity. Cell Metab. 2023;35:943\u2013e960949.","journal-title":"Cell Metab"},{"key":"2521_CR112","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/s41564-023-01363-5","volume":"8","author":"JX Han","year":"2023","unstructured":"Han JX, Tao ZH, Wang JL, Zhang L, Yu CY, Kang ZR, et al. Microbiota-derived tryptophan catabolites mediate the chemopreventive effects of statins on colorectal cancer. Nat Microbiol. 2023;8:919\u201333.","journal-title":"Nat Microbiol"},{"key":"2521_CR113","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.7150\/thno.92350","volume":"14","author":"Y Li","year":"2024","unstructured":"Li Y, Li Q, Yuan R, Wang Y, Guo C, Wang L. Bifidobacterium breve-derived indole-3-lactic acid ameliorates colitis-associated tumorigenesis by directing the differentiation of immature colonic macrophages. Theranostics. 2024;14:2719\u201335.","journal-title":"Theranostics"},{"key":"2521_CR114","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2347757","volume":"16","author":"J Su","year":"2024","unstructured":"Su J, Lin X, Li D, Yang C, Lv S, Chen X, et al. Prevotella copri exhausts intrinsic indole-3-pyruvic acid in the host to promote breast cancer progression: inactivation of AMPK via UHRF1-mediated negative regulation. Gut Microbes. 2024;16:2347757.","journal-title":"Gut Microbes"},{"key":"2521_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47868-3","volume":"15","author":"N Venkateswaran","year":"2024","unstructured":"Venkateswaran N, Garcia R, Lafita-Navarro MC, Hao YH, Perez-Castro L, Nogueira PAS, et al. Tryptophan fuels MYC-dependent liver tumorigenesis through indole 3-pyruvate synthesis. Nat Commun. 2024;15:4266.","journal-title":"Nat Commun"},{"key":"2521_CR116","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.cell.2020.07.038","volume":"182","author":"A Sadik","year":"2020","unstructured":"Sadik A, Somarribas Patterson LF, \u00d6zt\u00fcrk S, Mohapatra SR, Panitz V, Secker PF, Pf\u00e4nder P, Loth S, Salem H, Prentzell MT, et al. IL4I1 is a metabolic immune checkpoint that activates the AHR and promotes tumor progression. Cell. 2020;182:1252\u2013e12701234.","journal-title":"Cell"},{"key":"2521_CR117","doi-asserted-by":"publisher","unstructured":"Zeitler L, Fiore A, Meyer C, Russier M, Zanella G, Suppmann S, et al. Anti-ferroptotic mechanism of IL4i1-mediated amino acid metabolism. Elife. 2021;10:e64806. https:\/\/doi.org\/10.7554\/eLife.64806","DOI":"10.7554\/eLife.64806"},{"key":"2521_CR118","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41586-023-05728-y","volume":"615","author":"J Tintelnot","year":"2023","unstructured":"Tintelnot J, Xu Y, Lesker TR, Sch\u00f6nlein M, Konczalla L, Giannou AD, et al. Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature. 2023;615:168\u201374.","journal-title":"Nature"},{"key":"2521_CR119","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1488749","volume":"14","author":"PR Braadland","year":"2024","unstructured":"Braadland PR, Farnes I, Kure EH, Yaqub S, McCann A, Ueland PM, et al. Indole 3-acetate and response to therapy in borderline resectable or locally advanced pancreatic cancer. Front Oncol. 2024;14:1488749.","journal-title":"Front Oncol"},{"key":"2521_CR120","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/s41586-023-06990-w","volume":"626","author":"B Rimal","year":"2024","unstructured":"Rimal B, Collins SL, Tanes CE, Rocha ER, Granda MA, Solanki S, et al. Bile salt hydrolase catalyses formation of amine-conjugated bile acids. Nature. 2024;626:859\u201363.","journal-title":"Nature"},{"key":"2521_CR121","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41586-020-2047-9","volume":"579","author":"RA Quinn","year":"2020","unstructured":"Quinn RA, Melnik AV, Vrbanac A, Fu T, Patras KA, Christy MP, et al. Global chemical effects of the microbiome include new bile-acid conjugations. Nature. 2020;579:123\u20139.","journal-title":"Nature"},{"key":"2521_CR122","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41586-023-05989-7","volume":"617","author":"D Shalon","year":"2023","unstructured":"Shalon D, Culver RN, Grembi JA, Folz J, Treit PV, Shi H, et al. Profiling the human intestinal environment under physiological conditions. Nature. 2023;617:581\u201391.","journal-title":"Nature"},{"key":"2521_CR123","doi-asserted-by":"publisher","unstructured":"Ay \u00dc, Len\u00ed\u010dek M, Haider RS, Classen A, van Eijk H, Koelfat KVK, et al. Microbially conjugated bile salts found in human bile activate the bile salt receptors TGR5 and FXR. Hepatol Commun. 2024;8(4):e0383. https:\/\/doi.org\/10.1097\/HC9.0000000000000383","DOI":"10.1097\/HC9.0000000000000383"},{"key":"2521_CR124","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","volume":"576","author":"S Hang","year":"2019","unstructured":"Hang S, Paik D, Yao L, Kim E, Trinath J, Lu J, et al. Bile acid metabolites control T(H)17 and T(reg) cell differentiation. Nature. 2019;576:143\u20138.","journal-title":"Nature"},{"key":"2521_CR125","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41586-020-2193-0","volume":"581","author":"C Campbell","year":"2020","unstructured":"Campbell C, McKenney PT, Konstantinovsky D, Isaeva OI, Schizas M, Verter J, et al. Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells. Nature. 2020;581:475\u20139.","journal-title":"Nature"},{"key":"2521_CR126","doi-asserted-by":"publisher","unstructured":"Ishizawa M, Akagi D, Makishima M. Lithocholic acid is a vitamin D receptor ligand that acts preferentially in the ileum. Int J Mol Sci. 2018;19(7):1975. https:\/\/doi.org\/10.3390\/ijms19071975","DOI":"10.3390\/ijms19071975"},{"key":"2521_CR127","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.ymthe.2023.01.018","volume":"31","author":"J Li","year":"2023","unstructured":"Li J, Chen Y, Li R, Zhang X, Chen T, Mei F, et al. Gut microbial metabolite hyodeoxycholic acid targets the TLR4\/MD2 complex to attenuate inflammation and protect against sepsis. Mol Ther. 2023;31:1017\u201332.","journal-title":"Mol Ther"},{"key":"2521_CR128","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.1039\/C8FO01143E","volume":"9","author":"L Liu","year":"2018","unstructured":"Liu L, Dong W, Wang S, Zhang Y, Liu T, Xie R, et al. Deoxycholic acid disrupts the intestinal mucosal barrier and promotes intestinal tumorigenesis. Food Funct. 2018;9:5588\u201397.","journal-title":"Food Funct"},{"key":"2521_CR129","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jhep.2022.02.030","volume":"77","author":"R Sun","year":"2022","unstructured":"Sun R, Zhang Z, Bao R, Guo X, Gu Y, Yang W, et al. Loss of SIRT5 promotes bile acid-induced immunosuppressive microenvironment and hepatocarcinogenesis. J Hepatol. 2022;77:453\u201366.","journal-title":"J Hepatol"},{"issue":"1","key":"2521_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31141-6","volume":"13","author":"Y Shen","year":"2022","unstructured":"Shen Y, Lu C, Song Z, Qiao C, Wang J, Chen J, et al. Ursodeoxycholic acid reduces antitumor immunosuppression by inducing CHIP-mediated TGF-\u03b2 degradation. Nat Commun. 2022;13(1):3419.","journal-title":"Nat Commun"},{"key":"2521_CR131","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.ymthe.2022.10.014","volume":"31","author":"Q He","year":"2023","unstructured":"He Q, Wu J, Ke J, Zhang Q, Zeng W, Luo Z, et al. Therapeutic role of ursodeoxycholic acid in colitis-associated cancer via gut microbiota modulation. Mol Ther. 2023;31:585\u201398.","journal-title":"Mol Ther"},{"key":"2521_CR132","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jcmgh.2021.01.011","volume":"12","author":"J Leonhardt","year":"2021","unstructured":"Leonhardt J, Haider RS, Sponholz C, Leonhardt S, Drube J, Spengler K, et al. Circulating bile acids in liver failure activate TGR5 and induce monocyte dysfunction. Cell Mol Gastroenterol Hepatol. 2021;12:25\u201340.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2521_CR133","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06495-y","volume":"15","author":"X Jin","year":"2024","unstructured":"Jin X, Shang B, Wang J, Sun J, Li J, Liang B, et al. Farnesoid X receptor promotes non-small cell lung cancer metastasis by activating Jak2\/STAT3 signaling via transactivation of IL-6ST and IL-6 genes. Cell Death Dis. 2024;15:148.","journal-title":"Cell Death Dis"},{"key":"2521_CR134","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.apsb.2021.07.011","volume":"12","author":"L Zhao","year":"2022","unstructured":"Zhao L, Zhang H, Liu X, Xue S, Chen D, Zou J, et al. TGR5 deficiency activates antitumor immunity in non-small cell lung cancer via restraining M2 macrophage polarization. Acta Pharm Sin B. 2022;12:787\u2013800.","journal-title":"Acta Pharm Sin B"},{"key":"2521_CR135","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58809-z","volume":"16","author":"Y Liu","year":"2025","unstructured":"Liu Y, Zhu J, Jin Y, Sun Z, Wu X, Zhou H, et al. Disrupting bile acid metabolism by suppressing Fxr causes hepatocellular carcinoma induced by YAP activation. Nat Commun. 2025;16:3583.","journal-title":"Nat Commun"},{"key":"2521_CR136","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02107","volume":"8","author":"M Perez","year":"2017","unstructured":"Perez M, Ladero V, Del Rio B, Redruello B, de Jong A, Kuipers O, et al. The relationship among tyrosine decarboxylase and agmatine deiminase pathways in Enterococcus faecalis. Front Microbiol. 2017;8:2107.","journal-title":"Front Microbiol"},{"key":"2521_CR137","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1007\/s00726-016-2233-0","volume":"48","author":"M Sakanaka","year":"2016","unstructured":"Sakanaka M, Sugiyama Y, Kitakata A, Katayama T, Kurihara S. Carboxyspermidine decarboxylase of the prominent intestinal microbiota species bacteroides thetaiotaomicron is required for spermidine biosynthesis and contributes to normal growth. Amino Acids. 2016;48:2443\u201351.","journal-title":"Amino Acids"},{"key":"2521_CR138","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1080\/09168451.2018.1475211","volume":"82","author":"Y Sugiyama","year":"2018","unstructured":"Sugiyama Y, Nara M, Sakanaka M, Kitakata A, Okuda S, Kurihara S. Analysis of polyamine biosynthetic- and transport ability of human Indigenous bifidobacterium. Biosci Biotechnol Biochem. 2018;82:1606\u201314.","journal-title":"Biosci Biotechnol Biochem"},{"key":"2521_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2020.104064","volume":"72","author":"M Mikelsaar","year":"2020","unstructured":"Mikelsaar M, Stsepetova J, Mikelsaar R-H, Truusalu K, Smidt I, H\u00fctt P, et al. Polyamines of human strain Lactobacillus plantarum inducia induce modulation of innate immune markers. J Funct Foods. 2020;72:104064.","journal-title":"J Funct Foods"},{"key":"2521_CR140","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2012.00162","volume":"2","author":"LD Gamble","year":"2012","unstructured":"Gamble LD, Hogarty MD, Liu X, Ziegler DS, Marshall G, Norris MD, et al. Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastoma. Front Oncol. 2012;2:162.","journal-title":"Front Oncol"},{"key":"2521_CR141","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.912279","volume":"13","author":"J Lian","year":"2022","unstructured":"Lian J, Liang Y, Zhang H, Lan M, Ye Z, Lin B, et al. The role of polyamine metabolism in remodeling immune responses and blocking therapy within the tumor immune microenvironment. Front Immunol. 2022;13:912279.","journal-title":"Front Immunol"},{"key":"2521_CR142","doi-asserted-by":"publisher","DOI":"10.1038\/srep04548","volume":"4","author":"R Kibe","year":"2014","unstructured":"Kibe R, Kurihara S, Sakai Y, Suzuki H, Ooga T, Sawaki E, et al. Upregulation of colonic luminal polyamines produced by intestinal microbiota delays senescence in mice. Sci Rep. 2014;4:4548.","journal-title":"Sci Rep"},{"key":"2521_CR143","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jaci.2020.04.037","volume":"147","author":"GM Carriche","year":"2021","unstructured":"Carriche GM, Almeida L, St\u00fcve P, Velasquez L, Dhillon-LaBrooy A, Roy U, Lindenberg M, Strowig T, Plaza-Sirvent C, Schmitz I, et al. Regulating T-cell differentiation through the polyamine spermidine. J Allergy Clin Immunol. 2021;147:335\u2013e348311.","journal-title":"J Allergy Clin Immunol"},{"key":"2521_CR144","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.1016\/j.cell.2021.06.007","volume":"184","author":"DJ Puleston","year":"2021","unstructured":"Puleston DJ, Baixauli F, Sanin DE, Edwards-Hicks J, Villa M, Kabat AM, Kami\u0144ski MM, Stanckzak M, Weiss HJ, Grzes KM, et al. Polyamine metabolism is a central determinant of helper T cell lineage fidelity. Cell. 2021;184:4186\u2013e42024120.","journal-title":"Cell"},{"key":"2521_CR145","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.it.2020.09.007","volume":"41","author":"E Proietti","year":"2020","unstructured":"Proietti E, Rossini S, Grohmann U, Mondanelli G. Polyamines and kynurenines at the intersection of immune modulation. Trends Immunol. 2020;41:1037\u201350.","journal-title":"Trends Immunol"},{"key":"2521_CR146","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.immuni.2017.01.005","volume":"46","author":"G Mondanelli","year":"2017","unstructured":"Mondanelli G, Bianchi R, Pallotta MT, Orabona C, Albini E, Iacono A, et al. A relay pathway between arginine and tryptophan metabolism confers immunosuppressive properties on dendritic cells. Immunity. 2017;46:233\u201344.","journal-title":"Immunity"},{"key":"2521_CR147","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01565","volume":"10","author":"G Mondanelli","year":"2019","unstructured":"Mondanelli G, Iacono A, Allegrucci M, Puccetti P, Grohmann U. Immunoregulatory interplay between arginine and tryptophan metabolism in health and disease. Front Immunol. 2019;10:1565.","journal-title":"Front Immunol"},{"key":"2521_CR148","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.freeradbiomed.2020.10.029","volume":"161","author":"R Liu","year":"2020","unstructured":"Liu R, Li X, Ma H, Yang Q, Shang Q, Song L, et al. Spermidine endows macrophages anti-inflammatory properties by inducing mitochondrial superoxide-dependent AMPK activation, Hif-1\u03b1 upregulation and autophagy. Free Radic Biol Med. 2020;161:339\u201350.","journal-title":"Free Radic Biol Med"},{"key":"2521_CR149","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1038\/cdd.2016.71","volume":"23","author":"Q Yang","year":"2016","unstructured":"Yang Q, Zheng C, Cao J, Cao G, Shou P, Lin L, et al. Spermidine alleviates experimental autoimmune encephalomyelitis through inducing inhibitory macrophages. Cell Death Differ. 2016;23:1850\u201361.","journal-title":"Cell Death Differ"},{"key":"2521_CR150","doi-asserted-by":"publisher","unstructured":"Kay KE, Lee J, Hong ES, Beilis J, Dayal S, Wesley ER, et al. Tumor cell-derived spermidine promotes a protumorigenic immune microenvironment in glioblastoma via CD8\u2009+\u2009T cell Inhibition. J Clin Invest. 2024;135(2):e177824. https:\/\/doi.org\/10.1172\/JCI177824","DOI":"10.1172\/JCI177824"},{"key":"2521_CR151","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.cmet.2019.05.003","volume":"30","author":"DJ Puleston","year":"2019","unstructured":"Puleston DJ, Buck MD, Klein Geltink RI, Kyle RL, Caputa G, O\u2019Sullivan D, Cameron AM, Castoldi A, Musa Y, Kabat AM, et al. Polyamines and eIF5A hypusination modulate mitochondrial respiration and macrophage activation. Cell Metab. 2019;30:352\u2013e363358.","journal-title":"Cell Metab"},{"key":"2521_CR152","doi-asserted-by":"publisher","DOI":"10.1126\/science.abj3510","volume":"378","author":"M Al-Habsi","year":"2022","unstructured":"Al-Habsi M, Chamoto K, Matsumoto K, Nomura N, Zhang B, Sugiura Y, et al. Spermidine activates mitochondrial trifunctional protein and improves antitumor immunity in mice. Science. 2022;378:eabj3510.","journal-title":"Science"},{"key":"2521_CR153","doi-asserted-by":"publisher","unstructured":"Piha-Paul SA, Tolcher AW, Vandross AL, Spira AI, Armstrong M, Burns MR. 986 phase I dose-escalation trial of AMXT 1501 dicaprate plus difluoromethylornithine: a dual agent approach targeting immunosuppressive polyamine metabolism. J Immunother Cancer 2024, 12. https:\/\/doi.org\/10.1136\/jitc-2024-SITC2024.0986","DOI":"10.1136\/jitc-2024-SITC2024.0986"},{"key":"2521_CR154","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","volume":"11","author":"T Kawai","year":"2010","unstructured":"Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010;11:373\u201384.","journal-title":"Nat Immunol"},{"key":"2521_CR155","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.immuni.2024.03.004","volume":"57","author":"T Kawai","year":"2024","unstructured":"Kawai T, Ikegawa M, Ori D, Akira S. Decoding toll-like receptors: recent insights and perspectives in innate immunity. Immunity. 2024;57:649\u201373.","journal-title":"Immunity"},{"key":"2521_CR156","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/s41564-025-01930-y","volume":"10","author":"P Sardar","year":"2025","unstructured":"Sardar P, Beresford-Jones BS, Xia W, Shabana O, Suyama S, Ramos RJF, et al. Gut microbiota-derived hexa-acylated lipopolysaccharides enhance cancer immunotherapy responses. Nat Microbiol. 2025;10:795\u2013807.","journal-title":"Nat Microbiol"},{"key":"2521_CR157","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.immuni.2014.12.010","volume":"41","author":"R Caruso","year":"2014","unstructured":"Caruso R, Warner N, Inohara N, N\u00fa\u00f1ez G. NOD1 and NOD2: signaling, host defense, and inflammatory disease. Immunity. 2014;41:898\u2013908.","journal-title":"Immunity"},{"key":"2521_CR158","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.immuni.2016.09.009","volume":"45","author":"R Daill\u00e8re","year":"2016","unstructured":"Daill\u00e8re R, V\u00e9tizou M, Waldschmitt N, Yamazaki T, Isnard C, Poirier-Colame V, Duong CPM, Flament C, Lepage P, Roberti MP, et al. Enterococcus Hirae and Barnesiella intestinihominis facilitate Cyclophosphamide-Induced therapeutic Immunomodulatory effects. Immunity. 2016;45:931\u201343.","journal-title":"Immunity"},{"issue":"81","key":"2521_CR159","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abo2003","volume":"8","author":"Y Choi","year":"2023","unstructured":"Choi Y, Lichterman JN, Coughlin LA, Poulides N, Li W, Del Valle P, et al. Immune checkpoint blockade induces gut microbiota translocation that augments extraintestinal antitumor immunity. Sci Immunol. 2023;8(81):eabo2003.","journal-title":"Sci Immunol"},{"key":"2521_CR160","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-023-00446-9","volume":"9","author":"L Schorr","year":"2023","unstructured":"Schorr L, Mathies M, Elinav E, Puschhof J. Intracellular bacteria in cancer\u2014prospects and debates. NPJ Biofilms Microbiomes. 2023;9:76.","journal-title":"NPJ Biofilms Microbiomes"},{"key":"2521_CR161","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","volume":"178","author":"E Riquelme","year":"2019","unstructured":"Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W, Quesada P, Sahin I, Chandra V, San Lucas A, et al. Tumor Microbiome diversity and composition influence pancreatic cancer outcomes. Cell. 2019;178:795\u2013e806712.","journal-title":"Cell"},{"key":"2521_CR162","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59550-3","volume":"16","author":"Y Fu","year":"2025","unstructured":"Fu Y, Kim H, Lee DS, Han A-r, Heine H, Zamyatina A, et al. Structural insight into TLR4\/MD-2 activation by synthetic LPS mimetics with distinct binding modes. Nat Commun. 2025;16:4164.","journal-title":"Nat Commun"},{"key":"2521_CR163","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1158\/2159-8290.CD-21-0187","volume":"11","author":"S Chagani","year":"2021","unstructured":"Chagani S, Kwong LN. Cholangiocarcinoma risk factors open the floodgates for gut microbes and immunosuppressive myeloid cells. Cancer Discov. 2021;11:1014\u20135.","journal-title":"Cancer Discov"},{"key":"2521_CR164","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e29683","volume":"10","author":"J Ke","year":"2024","unstructured":"Ke J, Zhang CJ, Wang LZ, Xie FS, Wu HY, Li T, et al. Lipopolysaccharide promotes cancer cell migration and invasion through METTL3\/PI3K\/AKT signaling in human cholangiocarcinoma. Heliyon. 2024;10:e29683.","journal-title":"Heliyon"},{"key":"2521_CR165","doi-asserted-by":"publisher","first-page":"5380","DOI":"10.1172\/JCI137110","volume":"130","author":"E Loeuillard","year":"2020","unstructured":"Loeuillard E, Yang J, Buckarma E, Wang J, Liu Y, Conboy C, et al. Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma. J Clin Invest. 2020;130:5380\u201396.","journal-title":"J Clin Invest"},{"key":"2521_CR166","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1126\/science.abc9113","volume":"373","author":"ME Griffin","year":"2021","unstructured":"Griffin ME, Espinosa J, Becker JL, Luo JD, Carroll TS, Jha JK, et al. Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy. Science. 2021;373:1040\u20136.","journal-title":"Science"},{"key":"2521_CR167","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00958","volume":"10","author":"D Corridoni","year":"2019","unstructured":"Corridoni D, Shiraishi S, Chapman T, Steevels T, Muraro D, Th\u00e9z\u00e9nas ML, et al. NOD2 and TLR2 signal via TBK1 and PI31 to direct cross-presentation and CD8 T cell responses. Front Immunol. 2019;10:958.","journal-title":"Front Immunol"},{"key":"2521_CR168","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108677","volume":"34","author":"C Maisonneuve","year":"2021","unstructured":"Maisonneuve C, Tsang DKL, Foerster EG, Robert LM, Mukherjee T, Prescott D, et al. Nod1 promotes colorectal carcinogenesis by regulating the immunosuppressive functions of tumor-infiltrating myeloid cells. Cell Rep. 2021;34:108677.","journal-title":"Cell Rep"},{"key":"2521_CR169","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2314337121","volume":"121","author":"N Zhang","year":"2024","unstructured":"Zhang N, Zhang R, Jiang L, Gao Z, Xia W, Ma X, et al. Inhibition of colorectal cancer in Alzheimer\u2019s disease is mediated by gut microbiota via induction of inflammatory tolerance. Proc Natl Acad Sci U S A. 2024;121:e2314337121.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2521_CR170","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-63774-6","volume":"14","author":"Z Wu","year":"2024","unstructured":"Wu Z, Guo J, Zhang Z, Gao S, Huang M, Wang Y, et al. Bacteroidetes promotes esophageal squamous carcinoma invasion and metastasis through LPS-mediated TLR4\/Myd88\/NF-\u03baB pathway and inflammatory changes. Sci Rep. 2024;14:12827.","journal-title":"Sci Rep"},{"key":"2521_CR171","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01607-23","volume":"14","author":"A Gihawi","year":"2023","unstructured":"Gihawi A, Ge Y, Lu J, Puiu D, Xu A, Cooper CS, et al. Major data analysis errors invalidate cancer microbiome findings. mBio. 2023;14:e0160723.","journal-title":"mBio"},{"key":"2521_CR172","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41579-018-0029-9","volume":"16","author":"R Knight","year":"2018","unstructured":"Knight R, Vrbanac A, Taylor BC, Aksenov A, Callewaert C, Debelius J, et al. Best practices for analysing microbiomes. Nat Rev Microbiol. 2018;16:410\u201322.","journal-title":"Nat Rev Microbiol"},{"key":"2521_CR173","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tim.2018.11.003","volume":"27","author":"R Eisenhofer","year":"2019","unstructured":"Eisenhofer R, Minich JJ, Marotz C, Cooper A, Knight R, Weyrich LS. Contamination in low microbial biomass microbiome studies: issues and recommendations. Trends Microbiol. 2019;27:105\u201317.","journal-title":"Trends Microbiol"},{"key":"2521_CR174","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1526051","volume":"15","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Lv J, Jin S, Fu C, Liu B, Shen Y, et al. Gut microbiota derived metabolite trimethylamine N-oxide influences prostate cancer progression via the p38\/HMOX1 pathway. Front Pharmacol. 2024;15:1526051.","journal-title":"Front Pharmacol"},{"key":"2521_CR175","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s13402-024-00920-2","volume":"47","author":"W Zhang","year":"2024","unstructured":"Zhang W, Qin X, Zhang K, Ma J, Li M, Jin G, et al. Microbial metabolite trimethylamine-N-oxide induces intestinal carcinogenesis through inhibiting farnesoid X receptor signaling. Cell Oncol (Dordr). 2024;47:1183\u201399.","journal-title":"Cell Oncol (Dordr)"},{"key":"2521_CR176","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7043856","volume":"2022","author":"S Yang","year":"2022","unstructured":"Yang S, Dai H, Lu Y, Li R, Gao C, Pan S. Trimethylamine n-oxide promotes cell proliferation and angiogenesis in colorectal cancer. J Immunol Res. 2022;2022:7043856.","journal-title":"J Immunol Res"},{"key":"2521_CR177","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.840171","volume":"10","author":"Y Wu","year":"2022","unstructured":"Wu Y, Rong X, Pan M, Wang T, Yang H, Chen X, et al. Integrated analysis reveals the gut microbial metabolite TMAO promotes inflammatory hepatocellular carcinoma by upregulating POSTN. Front Cell Dev Biol. 2022;10:840171.","journal-title":"Front Cell Dev Biol"},{"key":"2521_CR178","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.cmet.2022.02.010","volume":"34","author":"H Wang","year":"2022","unstructured":"Wang H, Rong X, Zhao G, Zhou Y, Xiao Y, Ma D, Jin X, Wu Y, Yan Y, Yang H, et al. The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer. Cell Metab. 2022;34:581\u2013e594588.","journal-title":"Cell Metab"},{"key":"2521_CR179","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1182\/blood.2024025366","volume":"145","author":"R Prasad","year":"2025","unstructured":"Prasad R, Rehman A, Rehman L, Darbaniyan F, Blumenberg V, Schubert ML, et al. Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy. Blood. 2025;145:823\u201339.","journal-title":"Blood"},{"key":"2521_CR180","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s42255-020-0219-4","volume":"2","author":"T Wang","year":"2020","unstructured":"Wang T, Gnanaprakasam JNR, Chen X, Kang S, Xu X, Sun H, et al. Inosine is an alternative carbon source for CD8(+)-T-cell function under glucose restriction. Nat Metab. 2020;2:635\u201347.","journal-title":"Nat Metab"},{"key":"2521_CR181","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ccell.2024.01.002","volume":"42","author":"DD Klysz","year":"2024","unstructured":"Klysz DD, Fowler C, Malipatlolla M, Stuani L, Freitas KA, Chen Y, Meier S, Daniel B, Sandor K, Xu P, et al. Inosine induces stemness features in CAR-T cells and enhances potency. Cancer Cell. 2024;42:266\u2013e282268.","journal-title":"Cancer Cell"},{"key":"2521_CR182","doi-asserted-by":"publisher","first-page":"e2411813","DOI":"10.1002\/advs.202411813","volume":"12","author":"J Wang","year":"2025","unstructured":"Wang J, Wang J, Yu Z, Wen H, Zhao C, Zhong J, Xiao C, Li Y, Xu J, Wang J, et al. Targeting the Adenosine-Mediated metabolic immune checkpoint with engineered probiotic for enhanced Chemo-Immunotherapy. Adv Sci (Weinh). 2025;12:e2411813.","journal-title":"Adv Sci (Weinh)"},{"key":"2521_CR183","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.cmet.2021.12.009","volume":"34","author":"S Saveljeva","year":"2022","unstructured":"Saveljeva S, Sewell GW, Ramshorn K, Cader MZ, West JA, Clare S, Haag LM, de Almeida Rodrigues RP, Unger LW, Iglesias-Romero AB, et al. A purine metabolic checkpoint that prevents autoimmunity and autoinflammation. Cell Metab. 2022;34:106\u2013e124110.","journal-title":"Cell Metab"},{"key":"2521_CR184","doi-asserted-by":"publisher","first-page":"13132","DOI":"10.1073\/pnas.0605251103","volume":"103","author":"A Ohta","year":"2006","unstructured":"Ohta A, Gorelik E, Prasad SJ, Ronchese F, Lukashev D, Wong MK, et al. A2a adenosine receptor protects tumors from antitumor T cells. Proc Natl Acad Sci U S A. 2006;103:13132\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2521_CR185","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.cell.2019.01.036","volume":"176","author":"T Fu","year":"2019","unstructured":"Fu T, Coulter S, Yoshihara E, Oh TG, Fang S, Cayabyab F, Zhu Q, Zhang T, Leblanc M, Liu S, et al. FXR regulates intestinal cancer stem cell proliferation. Cell. 2019;176:1098\u2013e11121018.","journal-title":"Cell"},{"key":"2521_CR186","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-00890-8","volume":"20","author":"Y Yao","year":"2022","unstructured":"Yao Y, Li X, Xu B, Luo L, Guo Q, Wang X, et al. Cholecystectomy promotes colon carcinogenesis by activating the Wnt signaling pathway by increasing the deoxycholic acid level. Cell Commun Signal. 2022;20:71.","journal-title":"Cell Commun Signal"},{"key":"2521_CR187","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2120744","volume":"14","author":"D Jin","year":"2022","unstructured":"Jin D, Huang K, Xu M, Hua H, Ye F, Yan J, et al. Deoxycholic acid induces gastric intestinal metaplasia by activating STAT3 signaling and disturbing gastric bile acids metabolism and microbiota. Gut Microbes. 2022;14:2120744.","journal-title":"Gut Microbes"},{"key":"2521_CR188","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2203968","volume":"15","author":"Y Liu","year":"2023","unstructured":"Liu Y, Lau HC, Yu J. Microbial metabolites in colorectal tumorigenesis and cancer therapy. Gut Microbes. 2023;15:2203968.","journal-title":"Gut Microbes"},{"key":"2521_CR189","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature12347","volume":"499","author":"S Yoshimoto","year":"2013","unstructured":"Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature. 2013;499:97\u2013101.","journal-title":"Nature"},{"key":"2521_CR190","doi-asserted-by":"publisher","DOI":"10.1186\/s40659-023-00436-3","volume":"56","author":"J Abrigo","year":"2023","unstructured":"Abrigo J, Olgu\u00edn H, Tacchi F, Orozco-Aguilar J, Valero-Breton M, Soto J, et al. Cholic and deoxycholic acids induce mitochondrial dysfunction, impaired biogenesis and autophagic flux in skeletal muscle cells. Biol Res. 2023;56:30.","journal-title":"Biol Res"},{"key":"2521_CR191","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202410602","volume":"12","author":"S Lian","year":"2025","unstructured":"Lian S, Lu M, Jiajing L, Zhang B, Fang Y, Wang X, et al. Conjugated lithocholic acid activates hepatic TGR5 to promote lipotoxicity and MASLD-MASH transition by disrupting carnitine biosynthesis. Adv Sci. 2025;12:e2410602.","journal-title":"Adv Sci"},{"key":"2521_CR192","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.jhep.2023.07.005","volume":"79","author":"Q Song","year":"2023","unstructured":"Song Q, Zhang X, Liu W, Wei H, Liang W, Zhou Y, et al. Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma. J Hepatol. 2023;79:1352\u201365.","journal-title":"J Hepatol"},{"key":"2521_CR193","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/HEP.0000000000000047","volume":"78","author":"Y Che","year":"2023","unstructured":"Che Y, Chen G, Guo Q, Duan Y, Feng H, Xia Q. Gut microbial metabolite butyrate improves anticancer therapy by regulating intracellular calcium homeostasis. Hepatology. 2023;78:88\u2013102.","journal-title":"Hepatology"},{"key":"2521_CR194","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01380","volume":"11","author":"J Han","year":"2020","unstructured":"Han J, Zhang S, Xu Y, Pang Y, Zhang X, Hu Y, et al. Beneficial effect of antibiotics and microbial metabolites on expanded V\u03b42V\u03b39 T cells in hepatocellular carcinoma immunotherapy. Front Immunol. 2020;11:1380.","journal-title":"Front Immunol"},{"key":"2521_CR195","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg2697","volume":"9","author":"S Han","year":"2023","unstructured":"Han S, Bao X, Zou Y, Wang L, Li Y, Yang L, et al. <scp>d<\/scp>-lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma. Sci Adv. 2023;9:eadg2697.","journal-title":"Sci Adv"},{"key":"2521_CR196","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2016.00646","volume":"7","author":"C Guo","year":"2016","unstructured":"Guo C, Chen WD, Wang YD. TGR5, not only a metabolic regulator. Front Physiol. 2016;7:646.","journal-title":"Front Physiol"},{"key":"2521_CR197","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1016\/j.csbj.2021.04.029","volume":"19","author":"L Jiang","year":"2021","unstructured":"Jiang L, Zhang H, Xiao D, Wei H, Chen Y. Farnesoid x receptor (FXR): structures and ligands. Comput Struct Biotechnol J. 2021;19:2148\u201359.","journal-title":"Comput Struct Biotechnol J"},{"key":"2521_CR198","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00698-4","volume":"7","author":"W You","year":"2017","unstructured":"You W, Chen B, Liu X, Xue S, Qin H, Jiang H. Farnesoid X receptor, a novel proto-oncogene in non-small cell lung cancer, promotes tumor growth via directly transactivating CCND1. Sci Rep. 2017;7:591.","journal-title":"Sci Rep"},{"key":"2521_CR199","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-73736-7","volume":"14","author":"Y Li","year":"2024","unstructured":"Li Y, Zhao H, Shen Z, Zheng Y, Jiang Y, Song Y, et al. Enhancing DOX efficacy against NSCLC through UDCA-mediated modulation of the TGF-\u03b2\/MAPK autophagy pathways. Sci Rep. 2024;14:27169.","journal-title":"Sci Rep"},{"key":"2521_CR200","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1535563","volume":"13","author":"DM Kharazi","year":"2025","unstructured":"Kharazi DM, Karam L, El Boustany C, Ibrahim JN. Sodium butyrate and sodium propionate inhibit breast cancer cell migration and invasion through regulation of epithelial-to-mesenchymal transition and suppression of MEK\/ERK signaling pathway. Front Cell Dev Biol. 2025;13:1535563.","journal-title":"Front Cell Dev Biol"},{"key":"2521_CR201","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02159-1","volume":"10","author":"B Cui","year":"2025","unstructured":"Cui B, Luo H, He B, Liu X, Lv D, Zhang X, et al. Gut dysbiosis conveys psychological stress to activate LRP5\/\u03b2-catenin pathway promoting cancer stemness. Signal Transduct Target Ther. 2025;10:79.","journal-title":"Signal Transduct Target Ther"},{"key":"2521_CR202","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2023.100928","volume":"43","author":"Y Liu","year":"2023","unstructured":"Liu Y, Zhou Q, Ye F, Yang C, Jiang H. Gut microbiota-derived short-chain fatty acids promote prostate cancer progression via inducing cancer cell autophagy and M2 macrophage polarization. Neoplasia. 2023;43:100928.","journal-title":"Neoplasia"},{"key":"2521_CR203","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1158\/0008-5472.CAN-20-4090","volume":"81","author":"M Matsushita","year":"2021","unstructured":"Matsushita M, Fujita K, Hayashi T, Kayama H, Motooka D, Hase H, et al. Gut microbiota-derived short-chain fatty acids promote prostate cancer growth via IGF1 signaling. Cancer Res. 2021;81:4014\u201326.","journal-title":"Cancer Res"},{"key":"2521_CR204","doi-asserted-by":"publisher","first-page":"1503317","DOI":"10.3389\/fphar.2024.1503317","volume":"15","author":"V Rogovskii","year":"2024","unstructured":"Rogovskii V, Murugin VV, Vorobyev N, Popov S, Sturov N, Krasheninnikov A, Morozov A, Prokhorova M. Urolithin A increases the natural killer activity of PBMCs in patients with prostate cancer. Front Pharmacol. 2024;15:1503317.","journal-title":"Front Pharmacol"},{"key":"2521_CR205","doi-asserted-by":"publisher","first-page":"84140","DOI":"10.18632\/oncotarget.20493","volume":"8","author":"ET Alexander","year":"2017","unstructured":"Alexander ET, Minton A, Peters MC, Phanstiel Ot, Gilmour SK. A novel polyamine blockade therapy activates an anti-tumor immune response. Oncotarget. 2017;8:84140\u201352.","journal-title":"Oncotarget"},{"key":"2521_CR206","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-59677-1","volume":"14","author":"M Murayama","year":"2024","unstructured":"Murayama M, Hosonuma M, Kuramasu A, Kobayashi S, Sasaki A, Baba Y, et al. Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody. Sci Rep. 2024;14:11325.","journal-title":"Sci Rep"},{"key":"2521_CR207","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.ccell.2024.07.005","volume":"42","author":"Y Sun","year":"2024","unstructured":"Sun Y, Zhang X, Hang D, Lau HC, Du J, Liu C, Xie M, Pan Y, Wang L, Liang C, et al. Integrative plasma and fecal metabolomics identify functional metabolites in adenoma-colorectal cancer progression and as early diagnostic biomarkers. Cancer Cell. 2024;42:1386\u2013e14001388.","journal-title":"Cancer Cell"},{"key":"2521_CR208","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3350\/cmh.2022.0039","volume":"28","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zhang X, Chen S, Wang J, Yu S, Li Y, et al. Gut-derived lipopolysaccharide promotes alcoholic hepatosteatosis and subsequent hepatocellular carcinoma by stimulating neutrophil extracellular traps through toll-like receptor 4. Clin Mol Hepatol. 2022;28:522\u201339.","journal-title":"Clin Mol Hepatol"},{"key":"2521_CR209","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41418-019-0340-7","volume":"27","author":"WT Liu","year":"2020","unstructured":"Liu WT, Jing YY, Gao L, Li R, Yang X, Pan XR, et al. Lipopolysaccharide induces the differentiation of hepatic progenitor cells into myofibroblasts constitutes the hepatocarcinogenesis-associated microenvironment. Cell Death Differ. 2020;27:85\u2013101.","journal-title":"Cell Death Differ"},{"key":"2521_CR210","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1158\/2159-8290.CD-16-0932","volume":"7","author":"TM Loo","year":"2017","unstructured":"Loo TM, Kamachi F, Watanabe Y, Yoshimoto S, Kanda H, Arai Y, et al. Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity. Cancer Discov. 2017;7:522\u201338.","journal-title":"Cancer Discov"},{"issue":"72","key":"2521_CR211","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abl7209","volume":"7","author":"R Yamagishi","year":"2022","unstructured":"Yamagishi R, Kamachi F, Nakamura M, Yamazaki S, Kamiya T, Takasugi M, et al. Gasdermin D-mediated release of IL-33 from senescent hepatic stellate cells promotes obesity-associated hepatocellular carcinoma. Sci Immunol. 2022;7(72):eabl7209.","journal-title":"Sci Immunol"},{"key":"2521_CR212","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adp8266","volume":"10","author":"F Zhang","year":"2024","unstructured":"Zhang F, Jiang Q, Cai J, Meng F, Tang W, Liu Z, et al. Activation of NOD1 on tumor-associated macrophages augments CD8(+) T cell-mediated antitumor immunity in hepatocellular carcinoma. Sci Adv. 2024;10:eadp8266.","journal-title":"Sci Adv"},{"key":"2521_CR213","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nm.3444","volume":"20","author":"A Trompette","year":"2014","unstructured":"Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med. 2014;20:159\u201366.","journal-title":"Nat Med"},{"key":"2521_CR214","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00456","volume":"8","author":"K Wang","year":"2017","unstructured":"Wang K, Wang J, Wei F, Zhao N, Yang F, Ren X. Expression of TLR4 in non-small cell lung cancer is associated with PD-L1 and poor prognosis in patients receiving pulmonectomy. Front Immunol. 2017;8:456.","journal-title":"Front Immunol"},{"key":"2521_CR215","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3892\/ijo.2020.5068","volume":"57","author":"X Kang","year":"2020","unstructured":"Kang X, Li P, Zhang C, Zhao Y, Hu H, Wen G. The TLR4\/ERK\/PD\u2013L1 axis may contribute to NSCLC initiation. Int J Oncol. 2020;57:456\u201365.","journal-title":"Int J Oncol"},{"key":"2521_CR216","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116132","volume":"44","author":"Q Song","year":"2025","unstructured":"Song Q, Li X, Li Q, Shang S, Ma S, Zhai Z, et al. Bifidobacterium animalis suppresses non-small cell lung cancer progression and modulates tumor immunity through indole-3-acetic acid. Cell Rep. 2025;44:116132.","journal-title":"Cell Rep"},{"key":"2521_CR217","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.cell.2022.02.027","volume":"185","author":"A Fu","year":"2022","unstructured":"Fu A, Yao B, Dong T, Chen Y, Yao J, Liu Y, Li H, Bai H, Liu X, Zhang Y, et al. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer. Cell. 2022;185:1356\u2013e13721326.","journal-title":"Cell"},{"key":"2521_CR218","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109980","volume":"9","author":"H Yang","year":"2014","unstructured":"Yang H, Wang B, Wang T, Xu L, He C, Wen H, et al. Toll-like receptor 4 prompts human breast cancer cells invasiveness via lipopolysaccharide stimulation and is overexpressed in patients with lymph node metastasis. PLoS One. 2014;9:e109980.","journal-title":"PLoS One"},{"key":"2521_CR219","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074922","volume":"8","author":"D Mu","year":"2013","unstructured":"Mu D, Gao Z, Guo H, Zhou G, Sun B. Sodium butyrate induces growth inhibition and apoptosis in human prostate cancer DU145 cells by up-regulation of the expression of Annexin A1. PLoS One. 2013;8:e74922.","journal-title":"PLoS One"},{"key":"2521_CR220","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1528058","volume":"16","author":"J Lv","year":"2025","unstructured":"Lv J, Jin S, Zhou Y, Fu C, Shen Y, Liu B, et al. Gut microbiota-derived metabolite phenylacetylglutamine inhibits the progression of prostate cancer by suppressing the Wnt\/\u03b2-catenin signaling pathway. Front Pharmacol. 2025;16:1528058.","journal-title":"Front Pharmacol"},{"key":"2521_CR221","doi-asserted-by":"publisher","unstructured":"Yu Y, Li L, Yang Q, Xue J, Wang B, Xie M, et al. Akkermansia muciniphila metabolite inosine inhibits castration resistance in prostate cancer. Microorganisms. 2024;12(8):1653. https:\/\/doi.org\/10.3390\/microorganisms12081653","DOI":"10.3390\/microorganisms12081653"},{"key":"2521_CR222","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-022-01289-w","volume":"10","author":"W Zhong","year":"2022","unstructured":"Zhong W, Wu K, Long Z, Zhou X, Zhong C, Wang S, et al. Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-\u03baB-IL6-STAT3 axis. Microbiome. 2022;10:94.","journal-title":"Microbiome"},{"key":"2521_CR223","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/pros.23722","volume":"79","author":"S Jain","year":"2019","unstructured":"Jain S, Dash P, Minz AP, Satpathi S, Samal AG, Behera PK, et al. Lipopolysaccharide (LPS) enhances prostate cancer metastasis potentially through NF-\u03baB activation and recurrent dexamethasone administration fails to suppress it in vivo. Prostate. 2019;79:168\u201382.","journal-title":"Prostate"},{"key":"2521_CR224","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.3892\/ol.2013.1204","volume":"5","author":"MR V\u00e4is\u00e4nen","year":"2013","unstructured":"V\u00e4is\u00e4nen MR, Jukkola-Vuorinen A, Vuopala KS, Selander KS, Vaarala MH. Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer. Oncol Lett. 2013;5:1659\u201363.","journal-title":"Oncol Lett"},{"key":"2521_CR225","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20793-x","volume":"12","author":"ER Littmann","year":"2021","unstructured":"Littmann ER, Lee JJ, Denny JE, Alam Z, Maslanka JR, Zarin I, et al. Host immunity modulates the efficacy of microbiota transplantation for treatment of Clostridioides difficile infection. Nat Commun. 2021;12:755.","journal-title":"Nat Commun"},{"key":"2521_CR226","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202301097","volume":"10","author":"Y Yu","year":"2023","unstructured":"Yu Y, Wang W, Zhang F. The next generation fecal microbiota transplantation: to transplant bacteria or virome. Adv Sci. 2023;10:e2301097.","journal-title":"Adv Sci"},{"key":"2521_CR227","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41586-019-0878-z","volume":"565","author":"T Tanoue","year":"2019","unstructured":"Tanoue T, Morita S, Plichta DR, Skelly AN, Suda W, Sugiura Y, et al. A defined commensal consortium elicits CD8 T cells and anti-cancer immunity. Nature. 2019;565:600\u20135.","journal-title":"Nature"},{"key":"2521_CR228","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.immuni.2019.06.002","volume":"51","author":"A Bachem","year":"2019","unstructured":"Bachem A, Makhlouf C, Binger KJ, de Souza DP, Tull D, Hochheiser K, Whitney PG, Fernandez-Ruiz D, D\u00e4hling S, Kastenm\u00fcller W, et al. Microbiota-Derived Short-Chain fatty acids promote the memory potential of Antigen-Activated CD8(+) T cells. Immunity. 2019;51:285\u2013e297285.","journal-title":"Immunity"},{"key":"2521_CR229","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1126\/science.abf3363","volume":"371","author":"D Davar","year":"2021","unstructured":"Davar D, Dzutsev AK, McCulloch JA, Rodrigues RR, Chauvin JM, Morrison RM, et al. Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients. Science. 2021;371:595\u2013602.","journal-title":"Science"},{"key":"2521_CR230","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1126\/science.abb5920","volume":"371","author":"EN Baruch","year":"2021","unstructured":"Baruch EN, Youngster I, Ben-Betzalel G, Ortenberg R, Lahat A, Katz L, et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science. 2021;371:602\u20139.","journal-title":"Science"},{"key":"2521_CR231","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.aad1329","volume":"350","author":"M V\u00e9tizou","year":"2015","unstructured":"V\u00e9tizou M, Pitt JM, Daill\u00e8re R, Lepage P, Waldschmitt N, Flament C, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science. 2015;350:1079\u201384.","journal-title":"Science"},{"key":"2521_CR232","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daill\u00e8re R, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018;359:91\u20137.","journal-title":"Science"},{"key":"2521_CR233","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2025.05.014","author":"O DeLeon","year":"2025","unstructured":"DeLeon O, Mocanu M, Tan A, Sidebottom AM, Koval J, Ceccato HD, et al. Microbiome mismatches from microbiota transplants lead to persistent off-target metabolic and immunomodulatory effects. Cell. 2025. https:\/\/doi.org\/10.1016\/j.cell.2025.05.014.","journal-title":"Cell"},{"key":"2521_CR234","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.chom.2019.05.001","volume":"25","author":"BB Hsu","year":"2019","unstructured":"Hsu BB, Gibson TE, Yeliseyev V, Liu Q, Lyon L, Bry L, Silver PA, Gerber GK. Dynamic modulation of the gut microbiota and metabolome by bacteriophages in a mouse model. Cell Host Microbe. 2019;25:803\u2013e814805.","journal-title":"Cell Host Microbe"},{"key":"2521_CR235","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/femsre\/fuaa020","volume":"44","author":"TS Rasmussen","year":"2020","unstructured":"Rasmussen TS, Koefoed AK, Jakobsen RR, Deng L, Castro-Mej\u00eda JL, Brunse A, et al. Bacteriophage-mediated manipulation of the gut microbiome - promises and presents limitations. FEMS Microbiol Rev. 2020;44:507\u201321.","journal-title":"FEMS Microbiol Rev"},{"key":"2521_CR236","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba1590","volume":"6","author":"X Dong","year":"2020","unstructured":"Dong X, Pan P, Zheng DW, Bao P, Zeng X, Zhang XZ. Bioinorganic hybrid bacteriophage for modulation of intestinal microbiota to remodel tumor-immune microenvironment against colorectal cancer. Sci Adv. 2020;6:eaba1590.","journal-title":"Sci Adv"},{"key":"2521_CR237","doi-asserted-by":"publisher","first-page":"12194","DOI":"10.1021\/acsnano.4c00413","volume":"18","author":"L Lei","year":"2024","unstructured":"Lei L, Yan J, Xin K, Li L, Sun Q, Wang Y, et al. Engineered bacteriophage-based in situ vaccine remodels a tumor microenvironment and elicits potent antitumor immunity. ACS Nano. 2024;18:12194\u2013209.","journal-title":"ACS Nano"},{"key":"2521_CR238","doi-asserted-by":"publisher","unstructured":"Wang J, Lamolinara A, Conti L, Giangrossi M, Cui L, Morelli MB, et al. HER2-Displaying M13 bacteriophages induce therapeutic immunity against breast cancer. Cancers (Basel). 2022;14(16):4054. https:\/\/doi.org\/10.3390\/cancers14164054","DOI":"10.3390\/cancers14164054"},{"key":"2521_CR239","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.canlet.2018.03.030","volume":"424","author":"N Barati","year":"2018","unstructured":"Barati N, Razazan A, Nicastro J, Slavcev R, Arab A, Mosaffa F, et al. Immunogenicity and antitumor activity of the superlytic \u03bbF7 phage nanoparticles displaying a HER2\/neu-derived peptide AE37 in a tumor model of BALB\/c mice. Cancer Lett. 2018;424:109\u201316.","journal-title":"Cancer Lett"},{"key":"2521_CR240","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2390720","volume":"16","author":"MR Mahmud","year":"2024","unstructured":"Mahmud MR, Tamanna SK, Akter S, Mazumder L, Akter S, Hasan MR, et al. Role of bacteriophages in shaping gut microbial community. Gut Microbes. 2024;16:2390720.","journal-title":"Gut Microbes"},{"key":"2521_CR241","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.iotech.2020.11.001","volume":"8","author":"C Soto Chervin","year":"2020","unstructured":"Soto Chervin C, Gajewski TF. Microbiome-based interventions: therapeutic strategies in cancer immunotherapy. Immuno-Oncology Technology. 2020;8:12\u201320.","journal-title":"Immuno-Oncology Technology"},{"key":"2521_CR242","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.aac4255","volume":"350","author":"A Sivan","year":"2015","unstructured":"Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti\u2013PD-L1 efficacy. Science. 2015;350:1084\u20139.","journal-title":"Science"},{"key":"2521_CR243","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.chom.2021.08.001","volume":"29","author":"A Montalban-Arques","year":"2021","unstructured":"Montalban-Arques A, Katkeviciute E, Busenhart P, Bircher A, Wirbel J, Zeller G, Morsy Y, Borsig L, Glaus Garzon JF, M\u00fcller A, et al. Commensal clostridiales strains mediate effective anti-cancer immune response against solid tumors. Cell Host Microbe. 2021;29:1573\u2013e15881577.","journal-title":"Cell Host Microbe"},{"key":"2521_CR244","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41568-018-0070-z","volume":"18","author":"S Zhou","year":"2018","unstructured":"Zhou S, Gravekamp C, Bermudes D, Liu K. Tumour-targeting bacteria engineered to fight cancer. Nat Rev Cancer. 2018;18:727\u201343.","journal-title":"Nat Rev Cancer"},{"key":"2521_CR245","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1126\/science.add9667","volume":"378","author":"CR Gurbatri","year":"2022","unstructured":"Gurbatri CR, Arpaia N, Danino T. Engineering bacteria as interactive cancer therapies. Science. 2022;378:858\u201364.","journal-title":"Science"},{"key":"2521_CR246","doi-asserted-by":"publisher","first-page":"6560","DOI":"10.7150\/thno.99931","volume":"14","author":"B Xie","year":"2024","unstructured":"Xie B, Dong L, Wang L, Wang R, Li C. Supramolecularly engineered bacteria mediated calcium overload and immunotherapy of tumors. Theranostics. 2024;14:6560\u201370.","journal-title":"Theranostics"},{"key":"2521_CR247","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202304407","volume":"10","author":"B Xie","year":"2023","unstructured":"Xie B, Zhao H, Ding YF, Wang Z, Gao C, Li S, et al. Supramolecularly engineered conjugate of bacteria and cell membrane-coated magnetic nanoparticles for enhanced ferroptosis and immunotherapy of tumors. Adv Sci (Weinh). 2023;10:e2304407.","journal-title":"Adv Sci (Weinh)"},{"key":"2521_CR248","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.cell.2025.02.002","volume":"188","author":"Z Chang","year":"2025","unstructured":"Chang Z, Guo X, Li X, Wang Y, Zang Z, Pei S, Lu W, Li Y, Huang JD, Xiao Y, Liu C. Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization. Cell. 2025;188:1842\u2013e18571820.","journal-title":"Cell"},{"key":"2521_CR249","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114086","volume":"43","author":"J Liao","year":"2024","unstructured":"Liao J, Pan H, Huang G, Gong H, Chen Z, Yin T, et al. T cell cascade regulation initiates systemic antitumor immunity through living drug factory of anti-PD-1\/IL-12 engineered probiotics. Cell Rep. 2024;43:114086.","journal-title":"Cell Rep"},{"key":"2521_CR250","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16602-0","volume":"11","author":"DS Leventhal","year":"2020","unstructured":"Leventhal DS, Sokolovska A, Li N, Plescia C, Kolodziej SA, Gallant CW, et al. Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity. Nat Commun. 2020;11:2739.","journal-title":"Nat Commun"},{"key":"2521_CR251","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S0140-6736(18)31809-9","volume":"393","author":"A Reynolds","year":"2019","unstructured":"Reynolds A, Mann J, Cummings J, Winter N, Mete E, Te Morenga L. Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. Lancet. 2019;393:434\u201345.","journal-title":"Lancet"},{"key":"2521_CR252","doi-asserted-by":"publisher","first-page":"13247","DOI":"10.1021\/acs.jafc.9b04860","volume":"67","author":"Q Li","year":"2019","unstructured":"Li Q, Chen H, Zhang M, Wu T, Liu R, Zhang Z. Potential correlation between dietary fiber-suppressed microbial conversion of choline to trimethylamine and formation of methylglyoxal. J Agric Food Chem. 2019;67:13247\u201357.","journal-title":"J Agric Food Chem"},{"key":"2521_CR253","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2035659","volume":"14","author":"K Ka\u017amierczak-Siedlecka","year":"2022","unstructured":"Ka\u017amierczak-Siedlecka K, Skonieczna-\u017bydecka K, Hupp T, Duchnowska R, Marek-Trzonkowska N, Po\u0142om K. Next-generation probiotics - do they open new therapeutic strategies for cancer patients? Gut Microbes. 2022;14:2035659.","journal-title":"Gut Microbes"},{"key":"2521_CR254","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.celrep.2019.04.001","volume":"27","author":"K Greenhalgh","year":"2019","unstructured":"Greenhalgh K, Ramiro-Garcia J, Heinken A, Ullmann P, Bintener T, Pacheco MP, Baginska J, Shah P, Frachet A, Halder R, et al. Integrated in vitro and in Silico modeling delineates the molecular effects of a synbiotic regimen on Colorectal-Cancer-Derived cells. Cell Rep. 2019;27:1621\u2013e16321629.","journal-title":"Cell Rep"},{"key":"2521_CR255","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-025-04111-2","volume":"74","author":"Y Narikawa","year":"2025","unstructured":"Narikawa Y, Kuramasu A, Hosonuma M, Murayama M, Funayama E, Sasaki A, et al. Inosine shapes PD-1 blockade responses and synergizes with dual PD-1\/CTLA-4 immunotherapy to enhance antitumor immunity. Cancer Immunol Immunother. 2025;74:289.","journal-title":"Cancer Immunol Immunother"},{"key":"2521_CR256","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2300846","volume":"16","author":"SY Lee","year":"2024","unstructured":"Lee SY, Jhun J, Woo JS, Lee KH, Hwang SH, Moon J, et al. Gut microbiome-derived butyrate inhibits the immunosuppressive factors PD-L1 and IL-10 in tumor-associated macrophages in gastric cancer. Gut Microbes. 2024;16:2300846.","journal-title":"Gut Microbes"},{"key":"2521_CR257","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1017\/S0007114509991863","volume":"103","author":"KR Freeland","year":"2010","unstructured":"Freeland KR, Wolever TM. Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-alpha. Br J Nutr. 2010;103:460\u20136.","journal-title":"Br J Nutr"},{"key":"2521_CR258","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02546-x","volume":"7","author":"EE Canfora","year":"2017","unstructured":"Canfora EE, van der Beek CM, Jocken JWE, Goossens GH, Holst JJ, Olde Damink SWM, et al. Colonic infusions of short-chain fatty acid mixtures promote energy metabolism in overweight\/obese men: a randomized crossover trial. Sci Rep. 2017;7:2360.","journal-title":"Sci Rep"},{"key":"2521_CR259","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1136\/gutjnl-2019-318424","volume":"68","author":"ES Chambers","year":"2019","unstructured":"Chambers ES, Byrne CS, Morrison DJ, Murphy KG, Preston T, Tedford C, et al. Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses: a randomised cross-over trial. Gut. 2019;68:1430\u20138.","journal-title":"Gut"},{"key":"2521_CR260","doi-asserted-by":"publisher","DOI":"10.1093\/pcmedi\/pbae017","volume":"7","author":"EM Jacob","year":"2024","unstructured":"Jacob EM, Huang J, Chen M. Lipid nanoparticle-based mRNA vaccines: a new frontier in precision oncology. Precis Clin Med. 2024;7:pbae017.","journal-title":"Precis Clin Med"},{"issue":"793","key":"2521_CR261","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adr4458","volume":"17","author":"S Lu","year":"2025","unstructured":"Lu S, Li J, Li Y, Liu S, Liu Y, Liang Y, et al. Succinate-loaded tumor cell-derived microparticles reprogram tumor-associated macrophage metabolism. Sci Transl Med. 2025;17(793):eadr4458.","journal-title":"Sci Transl Med"},{"key":"2521_CR262","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.101487","volume":"31","author":"Y Dong","year":"2025","unstructured":"Dong Y, Li J, Dai Y, Zhang X, Wang T, Zhao B, et al. Redox-responsive metal-organic framework nanocapsules enhance tumor chemo-immunotherapy by modulating tumor metabolic reprogramming. Mater Today Bio. 2025;31:101487.","journal-title":"Mater Today Bio"},{"key":"2521_CR263","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2025.162048","volume":"511","author":"D Zhou","year":"2025","unstructured":"Zhou D, Zhang G, Zhu J, Ai C, Wang W, Zhao Y, et al. Lipid acid metabolism reprogramming nanoagent induces ferroptosis storm and cGAS-STING activation for metal-immunotherapy of triple negative breast cancer. Chem Eng J. 2025;511:162048.","journal-title":"Chem Eng J"},{"key":"2521_CR264","doi-asserted-by":"crossref","unstructured":"Davar D, Dzutsev AK, McCulloch JA, Rodrigues RR, Chauvin J-M, Morrison RM, Deblasio RN, Menna C, Ding Q, Pagliano O et al. Fecal microbiota transplant overcomes resistance to anti\u2013PD-1 therapy in melanoma patients. 2021, 371:595\u2013602.","DOI":"10.1126\/science.abf3363"},{"key":"2521_CR265","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/s41591-023-02453-x","volume":"29","author":"B Routy","year":"2023","unstructured":"Routy B, Lenehan JG, Miller WH Jr., Jamal R, Messaoudene M, Daisley BA, et al. Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial. Nat Med. 2023;29:2121\u201332.","journal-title":"Nat Med"},{"key":"2521_CR266","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.chom.2024.06.010","volume":"32","author":"Y Kim","year":"2024","unstructured":"Kim Y, Kim G, Kim S, Cho B, Kim SY, Do EJ, Bae DJ, Kim S, Kweon MN, Song JS, et al. Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor. Cell Host Microbe. 2024;32:1380\u2013e13931389.","journal-title":"Cell Host Microbe"},{"key":"2521_CR267","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41591-022-01694-6","volume":"28","author":"N Dizman","year":"2022","unstructured":"Dizman N, Meza L, Bergerot P, Alcantara M, Dorff T, Lyou Y, Frankel P, Cui Y, Mira V, Llamas M, et al. Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial. Nat Med. 2022;28:704\u201312.","journal-title":"Nat Med"},{"key":"2521_CR268","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1038\/s41591-024-03086-4","volume":"30","author":"H Ebrahimi","year":"2024","unstructured":"Ebrahimi H, Dizman N, Meza L, Malhotra J, Li X, Dorff T, Frankel P, Llamas-Quitiquit M, Hsu J, Zengin ZB, et al. Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial. Nat Med. 2024;30:2576\u201385.","journal-title":"Nat Med"},{"key":"2521_CR269","doi-asserted-by":"crossref","unstructured":"Perets R, Meshner S, Tirosh O, Eshar S, Metz-Breiner A, Ben-Shabat SK, Ben-Yehuda H, Haber E, Cohen-Asis M, Maurice-Dror C et al. Preliminary results from a FIH, open-label phase 1 study with BMC128, a rationally designed live bacterial consortium, in combination with nivolumab. 2024, 42:8631\u20138631.","DOI":"10.1200\/JCO.2024.42.16_suppl.8631"},{"key":"2521_CR270","unstructured":"A Phase 1b, Randomized, Open-Label Trial to Evaluate Safety, Engraftment, and Initial Signs of Clinical Activity of MB097 in Combination With Pembrolizumab in Melanoma Patients With Primary Resistance to an AntiPD1Containing Immunotherapy. (Merck S, Dohme LLC eds.)2024."},{"key":"2521_CR271","unstructured":"Phase A, Open III, Label. Safety And Preliminary Efficacy Study of MRx0518 In Combination With Pembrolizumab In Patients With Advanced Malignancies Who Have Progressed On PD-1\/PD-L1 Inhibitors. (Merck S, Dohme LLC eds.)2018."},{"key":"2521_CR272","unstructured":"Phase A. 1, Open-label study to evaluate the safety and tolerability of BMC128 in combination with nivolumab in patients with Non-small cell lung cancer (NSCLC), melanoma or renal cell carcinoma (RCC). 2022."},{"key":"2521_CR273","unstructured":"The Effect of Prebiotic Inulin on Patients Affected by Recurrent\/Metastatic Head and Neck Squamous Cell Carcinoma (R\/M HNSCC). Treated With Immune Checkpoint Inhibitors (ICIs): Princess Study. (Ospedale Santa Croce-Carle C, Universit\u00e0 degli Studi di T eds.)2023."},{"key":"2521_CR274","unstructured":"Cancer Nutrition Study. CaNS - A Pilot Study of Dietary Interventions in Cancer Patients Treated With Immune Checkpoint Inhibitors. 2024."},{"key":"2521_CR275","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.chom.2023.03.020","volume":"31","author":"S Porcari","year":"2023","unstructured":"Porcari S, Benech N, Valles-Colomer M, Segata N, Gasbarrini A, Cammarota G, et al. Key determinants of success in fecal microbiota transplantation: from microbiome to clinic. Cell Host Microbe. 2023;31:712\u201333.","journal-title":"Cell Host Microbe"},{"key":"2521_CR276","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1038\/s41591-022-01964-3","volume":"28","author":"G Ianiro","year":"2022","unstructured":"Ianiro G, Pun\u010doch\u00e1\u0159 M, Karcher N, Porcari S, Armanini F, Asnicar F, et al. Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases. Nat Med. 2022;28:1913\u201323.","journal-title":"Nat Med"},{"key":"2521_CR277","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1001\/jama.2017.17077","volume":"318","author":"D Kao","year":"2017","unstructured":"Kao D, Roach B, Silva M, Beck P, Rioux K, Kaplan GG, et al. Effect of oral capsule- vs colonoscopy-delivered fecal microbiota transplantation on recurrent clostridium difficile infection: a randomized clinical trial. JAMA. 2017;318:1985\u201393.","journal-title":"JAMA"},{"key":"2521_CR278","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1158\/2159-8290.CD-24-0066","volume":"14","author":"IC Glitza","year":"2024","unstructured":"Glitza IC, Seo YD, Spencer CN, Wortman JR, Burton EM, Alayli FA, Loo CP, Gautam S, Damania A, Densmore J, et al. Randomized Placebo-Controlled, Biomarker-Stratified phase Ib Microbiome modulation in melanoma: impact of antibiotic preconditioning on Microbiome and immunity. Cancer Discov. 2024;14:1161\u201375.","journal-title":"Cancer Discov"},{"key":"2521_CR279","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02113-9","volume":"23","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Li Y, Zhao H. Spatiotemporal metabolomic approaches to the cancer-immunity panorama: a methodological perspective. Mol Cancer. 2024;23:202.","journal-title":"Mol Cancer"},{"key":"2521_CR280","doi-asserted-by":"publisher","unstructured":"Moreira MJ, Pintado M, Almeida J. Are Aptamer-Based biosensors the future of the detection of the human gut Microbiome?-A systematic review and Meta-Analysis. Biosens (Basel). 2024;14(9):423. https:\/\/doi.org\/10.3390\/bios14090423","DOI":"10.3390\/bios14090423"},{"key":"2521_CR281","doi-asserted-by":"publisher","DOI":"10.1038\/s44303-024-00025-3","volume":"2","author":"H Zhang","year":"2024","unstructured":"Zhang H, Lu KH, Ebbini M, Huang P, Lu H, Li L. Mass spectrometry imaging for spatially resolved multi-omics molecular mapping. Npj Imaging. 2024;2:20.","journal-title":"Npj Imaging"},{"key":"2521_CR282","doi-asserted-by":"publisher","DOI":"10.1111\/imr.70033","volume":"331","author":"W Awad","year":"2025","unstructured":"Awad W, Abdelaal MR, Letoga V, McCluskey J, Rossjohn J. Molecular insights into MR1-mediated T cell immunity: lessons learned and unanswered questions. Immunol Rev. 2025;331:e70033.","journal-title":"Immunol Rev"},{"key":"2521_CR283","doi-asserted-by":"crossref","unstructured":"Nunes JB, Ijsselsteijn ME, Abdelaal T, Ursem R, van der Ploeg M, Giera M, Everts B, Mahfouz A, Heijs B, de Miranda NFCC. Integration of mass cytometry and mass spectrometry imaging for spatially resolved single-cell metabolic profiling. Nat Methods. 2024;21:1796\u2013800.","DOI":"10.1038\/s41592-024-02392-6"},{"key":"2521_CR284","first-page":"13838","volume":"96","author":"H Yang","year":"2024","unstructured":"Yang H, O\u2019Keefe I, Smith RD, Sumner KP, Sherman ME, Goodlett DR, et al. A multimodal system for lipid A structural analysis from a single colony. Anal Chem. 2024;96:13838\u201345.","journal-title":"Anal Chem"},{"key":"2521_CR285","doi-asserted-by":"publisher","unstructured":"Wang W, He Y, He S, Deng L, Wang H, Cao Z, et al. A Brief Review of Aptamer-Based Biosensors in Recent Years. Biosensors (Basel). 2025;15(2):120. https:\/\/doi.org\/10.3390\/bios15020120","DOI":"10.3390\/bios15020120"},{"key":"2521_CR286","doi-asserted-by":"crossref","unstructured":"Chen S, Zhang Y, Li X, Zhang Y, Zeng Y: Driving innovations in cancer research through spatial metabolomics: a bibliometric review of trends and hotspot. Front Immunol. 2025;16:1589943.","DOI":"10.3389\/fimmu.2025.1589943"},{"key":"2521_CR287","doi-asserted-by":"crossref","unstructured":"Buglakova E, Ekel\u00f6f M, Schwaiger-Haber M, Schlicker L, Molenaar MR, Shahraz M, Stuart L, Eisenbarth A, Hilsenstein V, Patti GJ, et al: Spatial single-cell isotope tracing reveals heterogeneity of de novo fatty acid synthesis in cancer. Nature Metabolism. 2024;6:1695-1711.","DOI":"10.1038\/s42255-024-01118-4"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02521-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02521-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02521-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T14:03:18Z","timestamp":1767794598000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-025-02521-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":287,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2521"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02521-5","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}